Effective October 1, 2023 - December 31, 2023
HCPCS | Description | Labeler name | NDC | Drug name | Dosage | Package size | Package quantity | Billable units | Billable units / pkg |
---|---|---|---|---|---|---|---|---|---|
A9575 |
Inj gadoterate meglumi 0.1ml | GE HEALTHCARE | 00407-2943-01 | Clariscan | 0.1 ML | 10 | 10 | 100 | 1000 |
A9575 |
Inj gadoterate meglumi 0.1ml | GE HEALTHCARE | 00407-2943-02 | Clariscan | 0.1 ML | 15 | 10 | 150 | 1500 |
A9575 |
Inj gadoterate meglumi 0.1ml | GE HEALTHCARE | 00407-2943-05 | Clariscan | 0.1 ML | 20 | 10 | 200 | 2000 |
A9575 |
Inj gadoterate meglumi 0.1ml | GUERBET LLC | 67684-2000-00 | Dotarem | 0.1 ML | 5 | 10 | 50 | 500 |
A9575 |
Inj gadoterate meglumi 0.1ml | GUERBET LLC | 67684-2000-01 | Dotarem | 0.1 ML | 10 | 10 | 100 | 1000 |
A9575 |
Inj gadoterate meglumi 0.1ml | GUERBET LLC | 67684-2000-05 | Dotarem | 0.1 ML | 10 | 5 | 100 | 500 |
A9575 |
Inj gadoterate meglumi 0.1ml | GUERBET LLC | 67684-2000-06 | Dotarem | 0.1 ML | 15 | 5 | 150 | 750 |
A9575 |
Inj gadoterate meglumi 0.1ml | Guerbet, Llc | 67684-2001-00 | Dotarem | 0.1 ML | 5 | 10 | 50 | 500 |
A9575 |
Inj gadoterate meglumi 0.1ml | GUERBET LLC | 67684-2001-01 | Dotarem | 0.1 ML | 10 | 10 | 100 | 1000 |
A9575 |
Inj gadoterate meglumi 0.1ml | GUERBET LLC | 67684-2001-02 | Dotarem | 0.1 ML | 15 | 10 | 150 | 1500 |
A9575 |
Inj gadoterate meglumi 0.1ml | GUERBET LLC | 67684-2001-03 | Dotarem | 0.1 ML | 20 | 10 | 200 | 2000 |
A9575 |
Inj gadoterate meglumi 0.1ml | GUERBET LLC | 67684-2001-04 | Dotarem | 0.1 ML | 100 | 6 | 1000 | 6000 |
A9575 |
Inj gadoterate meglumi 0.1ml | GUERBET LLC | 67684-3001-01 | Dotarem | 0.1 ML | 10 | 10 | 100 | 1000 |
A9575 |
Inj gadoterate meglumi 0.1ml | GUERBET LLC | 67684-3001-02 | Dotarem | 0.1 ML | 15 | 10 | 150 | 1500 |
A9575 |
Inj gadoterate meglumi 0.1ml | GUERBET LLC | 67684-3001-03 | Dotarem | 0.1 ML | 20 | 10 | 200 | 2000 |
A9575 |
Inj gadoterate meglumi 0.1ml | GE HEALTHCARE | 00407-2943-06 | Gadoterate Meglumine | 0.1 ML | 5 | 10 | 50 | 500 |
A9575 |
Inj gadoterate meglumi 0.1ml | GE HEALTHCARE | 00407-2943-12 | Gadoterate Meglumine | 0.1 ML | 10 | 10 | 100 | 1000 |
A9575 |
Inj gadoterate meglumi 0.1ml | GE HEALTHCARE | 00407-2943-17 | Gadoterate Meglumine | 0.1 ML | 15 | 10 | 150 | 1500 |
A9575 |
Inj gadoterate meglumi 0.1ml | GE HEALTHCARE | 00407-2943-22 | Gadoterate Meglumine | 0.1 ML | 20 | 10 | 200 | 2000 |
A9575 |
Inj gadoterate meglumi 0.1ml | GE HEALTHCARE | 00407-2943-70 | Gadoterate Meglumine | 0.1 ML | 100 | 10 | 1000 | 10000 |
A9575 |
Inj gadoterate meglumi 0.1ml | FRESENIUS KABI USA, LLC | 65219-0080-05 | GADOTERATE MEGLUMINE | 0.1 ML | 5 | 10 | 50 | 500 |
A9575 |
Inj gadoterate meglumi 0.1ml | FRESENIUS KABI USA, LLC | 65219-0082-10 | GADOTERATE MEGLUMINE | 0.1 ML | 10 | 10 | 100 | 1000 |
A9575 |
Inj gadoterate meglumi 0.1ml | FRESENIUS KABI USA, LLC | 65219-0084-15 | GADOTERATE MEGLUMINE | 0.1 ML | 15 | 10 | 150 | 1500 |
A9575 |
Inj gadoterate meglumi 0.1ml | FRESENIUS KABI USA, LLC | 65219-0086-20 | GADOTERATE MEGLUMINE | 0.1 ML | 20 | 10 | 200 | 2000 |
A9575 |
Inj gadoterate meglumi 0.1ml | FRESENIUS KABI USA, LLC | 65219-0088-50 | GADOTERATE MEGLUMINE | 0.1 ML | 100 | 6 | 1000 | 6000 |
A9576 |
Inj prohance multipack | BRACCO DIAGNOSTICS | 00270-1111-70 | Prohance Multipack | 1 ML | 50 | 5 | 50 | 250 |
A9577 |
Inj multihance | BRACCO DIAGNOSTICS | 00270-5164-12 | Multihance | 1 ML | 5 | 5 | 5 | 25 |
A9577 |
Inj multihance | BRACCO DIAGNOSTICS | 00270-5164-13 | Multihance | 1 ML | 10 | 5 | 10 | 50 |
A9577 |
Inj multihance | BRACCO DIAGNOSTICS | 00270-5164-14 | Multihance | 1 ML | 15 | 5 | 15 | 75 |
A9577 |
Inj multihance | BRACCO DIAGNOSTICS | 00270-5164-15 | Multihance | 1 ML | 20 | 5 | 20 | 100 |
A9578 |
Inj multihance multipack | BRACCO DIAGNOSTICS | 00270-5264-16 | Multihance Multipack | 1 ML | 50 | 5 | 50 | 250 |
A9578 |
Inj multihance multipack | BRACCO DIAGNOSTICS | 00270-5264-17 | Multihance Multipack | 1 ML | 100 | 5 | 100 | 500 |
A9579 |
Gad-base mr contrast nos,1ml | GE HEALTHCARE | 00407-0690-05 | Omniscan | 1 ML | 5 | 10 | 5 | 50 |
A9579 |
Gad-base mr contrast nos,1ml | GE HEALTHCARE | 00407-0690-10 | Omniscan | 1 ML | 10 | 10 | 10 | 100 |
A9579 |
Gad-base mr contrast nos,1ml | GE HEALTHCARE | 00407-0690-12 | Omniscan | 1 ML | 10 | 10 | 10 | 100 |
A9579 |
Gad-base mr contrast nos,1ml | GE HEALTHCARE | 00407-0690-15 | Omniscan | 1 ML | 15 | 10 | 15 | 150 |
A9579 |
Gad-base mr contrast nos,1ml | GE HEALTHCARE | 00407-0690-17 | Omniscan | 1 ML | 15 | 10 | 15 | 150 |
A9579 |
Gad-base mr contrast nos,1ml | GE HEALTHCARE | 00407-0690-20 | Omniscan | 1 ML | 20 | 10 | 20 | 200 |
A9579 |
Gad-base mr contrast nos,1ml | GE HEALTHCARE | 00407-0690-22 | Omniscan | 1 ML | 20 | 10 | 20 | 200 |
A9579 |
Gad-base mr contrast nos,1ml | GE HEALTHCARE | 00407-0690-70 | Omniscan | 1 ML | 100 | 10 | 100 | 1000 |
A9579 |
Gad-base mr contrast nos,1ml | BRACCO DIAGNOSTICS | 00270-1111-16 | Prohance Prefilled Syringes | 1 ML | 10 | 5 | 10 | 50 |
A9579 |
Gad-base mr contrast nos,1ml | BRACCO DIAGNOSTICS | 00270-1111-45 | Prohance Prefilled Syringes | 1 ML | 17 | 5 | 17 | 85 |
A9579 |
Gad-base mr contrast nos,1ml | BRACCO DIAGNOSTICS | 00270-1111-01 | Prohance | 1 ML | 10 | 5 | 10 | 50 |
A9579 |
Gad-base mr contrast nos,1ml | BRACCO DIAGNOSTICS | 00270-1111-02 | Prohance | 1 ML | 15 | 5 | 15 | 75 |
A9579 |
Gad-base mr contrast nos,1ml | BRACCO DIAGNOSTICS | 00270-1111-03 | Prohance | 1 ML | 20 | 5 | 20 | 100 |
A9579 |
Gad-base mr contrast nos,1ml | BRACCO DIAGNOSTICS | 00270-1111-04 | Prohance | 1 ML | 5 | 5 | 5 | 25 |
A9579 |
Gad-base mr contrast nos,1ml | BRACCO DIAGNOSTICS | 00270-1111-85 | PROHANCE | 1 ML | 100 | 5 | 100 | 500 |
A9579 |
Gad-base mr contrast nos,1ml | BAYER HEALTHCARE PHARMACEUTICALS INC. | 50419-0188-01 | Magnevist 46.9% | 1 ML | 10 | 20 | 10 | 200 |
A9579 |
Gad-base mr contrast nos,1ml | BAYER HEALTHCARE PHARMACEUTICALS INC. | 50419-0188-02 | Magnevist 46.9% | 1 ML | 20 | 20 | 20 | 400 |
A9579 |
Gad-base mr contrast nos,1ml | BAYER HEALTHCARE PHARMACEUTICALS INC. | 50419-0188-05 | Magnevist 46.9% | 1 ML | 5 | 20 | 5 | 100 |
HCPCS | Description | Labeler name | NDC | Drug name | Dosage | Package size | Package quantity | Billable units | Billable units / pkg |
---|---|---|---|---|---|---|---|---|---|
91318 |
SARSCOV2 VAC 3MCG TRS-SUC IM | Pfizer | 59267-4315-02 | COVID-19 Vaccine 2023-2024 | 0.3 ML | 1 | 10 | 3 | 30 |
91319 |
SARSCV2 VAC 10MCG TRS-SUC IM | Pfizer | 59267-4331-02 | COVID-19 Vaccine 2023-2024 | 0.3 ML | 1 | 10 | 1 | 10 |
91320 |
SARSCV2 VAC 30MCG TRS-SUC IM | Pfizer | 00069-2362-10 | COMIRNATY 2023-2024 | 0.3 ML | 1 | 10 | 1 | 10 |
91320 |
SARSCV2 VAC 30MCG TRS-SUC IM | Pfizer | 00069-2392-10 | COMIRNATY 2023-2024 | 0.3 ML | 1 | 10 | 1 | 10 |
91321 |
SARSCOV2 VAC 25 MCG/.25ML IM | Moderna | 80777-0287-92 | COVID-19 Vaccine 2023-2024 | 0.25 ML | 1 | 10 | 1 | 10 |
91322 |
SARSCOV2 VAC 50 MCG/0.5ML IM | Moderna | 80777-0102-96 | SPIKEVAX 2023-2024 | 0.5 ML | 1 | 10 | 1 | 10 |
91322 |
SARSCOV2 VAC 50 MCG/0.5ML IM | Moderna | 80777-0102-93 | SPIKEVAX 2023-2024 | 0.5 ML | 1 | 10 | 1 | 10 |
P9041 |
Albumin (human),5%, 50ml | Grifols | 68516-5214-05 | Albutein 5% | 50 ML | 50 | 1 | 1 | 1 |
P9041 |
Albumin (human),5%, 50ml | Octapharma USA | 68982-0623-01 | Albumin (Human) | 50 ML | 100 | 1 | 2 | 2 |
P9045 |
Albumin (human), 5%, 250 ml | Octapharma USA | 68982-0623-02 | Albumin (Human) | 250 ML | 250 | 1 | 1 | 1 |
P9045 |
Albumin (human), 5%, 250 ml | Octapharma USA | 68982-0623-03 | Albumin (Human) | 250 ML | 500 | 1 | 2 | 2 |
P9045 |
Albumin (human), 5%, 250 ml | CSL Behring | 00053-7670-31 | Albuminar-5 | 250 ML | 250 | 1 | 1 | 1 |
P9045 |
Albumin (human), 5%, 250 ml | CSL Behring | 00053-7670-32 | Albuminar-5 | 250 ML | 500 | 1 | 2 | 2 |
P9045 |
Albumin (human), 5%, 250 ml | Bio Products Laboratory USA, Inc. | 64208-2510-01 | ALBUMINEX 5% | 250 ML | 250 | 1 | 1 | 1 |
P9045 |
Albumin (human), 5%, 250 ml | Bio Products Laboratory USA, Inc. | 64208-2510-05 | ALBUMINEX 5% | 250 ML | 500 | 1 | 2 | 2 |
P9045 |
Albumin (human), 5%, 250 ml | CSL Behring | 44206-0310-25 | Alburx | 250 ML | 250 | 1 | 1 | 1 |
P9045 |
Albumin (human), 5%, 250 ml | CSL Behring | 44206-0310-50 | Alburx | 250 ML | 500 | 1 | 2 | 2 |
P9045 |
Albumin (human), 5%, 250 ml | Grifols | 68516-5214-02 | Albutein® 5% Albumin 500 ml | 250 ML | 500 | 1 | 2 | 2 |
P9045 |
Albumin (human), 5%, 250 ml | Kedrion Biopharma | 76125-0790-25 | Albuked 5 | 250 ML | 250 | 1 | 1 | 1 |
P9045 |
Albumin (human), 5%, 250 ml | Grifols | 68516-5214-01 | Albutein® 5% | 250 ML | 250 | 1 | 1 | 1 |
P9045 |
Albumin (human), 5%, 250 ml | Baxter | 00944-0491-01 | Buminate | 250 ML | 250 | 1 | 1 | 1 |
P9045 |
Albumin (human), 5%, 250 ml | Baxter | 00944-0491-02 | Buminate | 250 ML | 500 | 1 | 2 | 2 |
P9045 |
Albumin (human), 5%, 250 ml | Talecris | 13533-0685-20 | Plasbumin-5 | 250 ML | 50 | 1 | 0.2 | 0.2 |
P9045 |
Albumin (human), 5%, 250 ml | Talecris | 13533-0685-25 | Plasbumin-5 | 250 ML | 250 | 1 | 1 | 1 |
P9045 |
Albumin (human), 5%, 250 ml | Talecris | 13533-0690-20 | Plasbumin-5 | 250 ML | 50 | 1 | 0.2 | 0.2 |
P9045 |
Albumin (human), 5%, 250 ml | Talecris | 13533-0690-25 | Plasbumin-5 | 250 ML | 250 | 1 | 1 | 1 |
P9046 |
Albumin (human), 25%, 20 ml | Grifols | 68516-5216-05 | Albutein 25% | 20 ML | 20 | 1 | 1 | 1 |
P9047 |
Albumin (human), 25%, 50ml | Kedrion Biopharma | 76125-0784-10 | Albuked 25 | 50 ML | 100 | 1 | 2 | 2 |
P9047 |
Albumin (human), 25%, 50ml | Kedrion Biopharma | 76125-0784-25 | Albuked 25 | 50 ML | 50 | 1 | 1 | 1 |
P9047 |
Albumin (human), 25%, 50ml | Grifols | 68516-5216-01 | Albutein® 25% | 50 ML | 50 | 1 | 1 | 1 |
P9047 |
Albumin (human), 25%, 50ml | Grifols | 68516-5216-02 | Albutein® 25% Albumin 100 ml | 50 ML | 100 | 1 | 2 | 2 |
P9047 |
Albumin (human), 25%, 50ml | Baxter | 00944-0490-01 | Buminate | 50 ML | 20 | 1 | 0.4 | 0.4 |
P9047 |
Albumin (human), 25%, 50ml | CSL Behring | 44206-0251-05 | Alburx | 50 ML | 50 | 1 | 1 | 1 |
P9047 |
Albumin (human), 25%, 50ml | CSL Behring | 44206-0251-10 | Alburx | 50 ML | 100 | 1 | 2 | 2 |
P9047 |
Albumin (human), 25%, 50ml | Grifols | 68516-5216-07 | Albutein | 50 ML | 50 | 1 | 1 | 1 |
P9047 |
Albumin (human), 25%, 50ml | Grifols | 68516-5216-08 | Albutein | 50 ML | 100 | 1 | 2 | 2 |
P9047 |
Albumin (human), 25%, 50ml | Bio Products Laboratory USA, Inc. | 64208-2512-03 | ALBUMINEX 25% | 50 ML | 50 | 1 | 1 | 1 |
P9047 |
Albumin (human), 25%, 50ml | Bio Products Laboratory USA, Inc. | 64208-2512-07 | ALBUMINEX 25% | 50 ML | 100 | 1 | 2 | 2 |
P9047 |
Albumin (human), 25%, 50ml | Octapharma USA | 68982-0643-01 | Albumin (Human) | 50 ML | 50 | 1 | 1 | 1 |
P9047 |
Albumin (human), 25%, 50ml | Octapharma USA | 68982-0643-02 | Albumin (Human) | 50 ML | 100 | 1 | 2 | 2 |
P9047 |
Albumin (human), 25%, 50ml | CSL Behring | 00053-7680-32 | Albuminar-25 | 50 ML | 50 | 1 | 1 | 1 |
P9047 |
Albumin (human), 25%, 50ml | CSL Behring | 00053-7680-33 | Albuminar-25 | 50 ML | 100 | 1 | 2 | 2 |
P9047 |
Albumin (human), 25%, 50ml | Baxter | 00944-0493-01 | Flexbumin | 50 ML | 50 | 1 | 1 | 1 |
P9047 |
Albumin (human), 25%, 50ml | Baxter | 00944-0493-02 | Flexbumin | 50 ML | 100 | 1 | 1 | 2 |
P9047 |
Albumin (human), 25%, 50ml | Grifols | 61953-0002-01 | Human Albumin Grifols | 50 ML | 50 | 1 | 1 | 1 |
P9047 |
Albumin (human), 25%, 50ml | Grifols | 61953-0002-02 | Human Albumin Grifols | 50 ML | 100 | 1 | 2 | 2 |
P9047 |
Albumin (human), 25%, 50ml | Kedrion Biopharma | 76179-0025-01 | Kedbumin | 50 ML | 50 | 1 | 1 | 1 |
P9047 |
Albumin (human), 25%, 50ml | Kedrion Biopharma | 76179-0025-02 | Kedbumin | 50 ML | 50 | 1 | 1 | 1 |
P9047 |
Albumin (human), 25%, 50ml | Kedrion Biopharma | 76179-0025-04 | Kedbumin | 50 ML | 100 | 1 | 2 | 2 |
P9047 |
Albumin (human), 25%, 50ml | Talecris | 13533-0684-16 | Plasbumin-25 | 50 ML | 20 | 1 | 0.4 | 0.4 |
P9047 |
Albumin (human), 25%, 50ml | Talecris | 13533-0684-20 | Plasbumin-25 | 50 ML | 50 | 1 | 1 | 1 |
P9047 |
Albumin (human), 25%, 50ml | Talecris | 13533-0684-71 | Plasbumin-25 | 50 ML | 100 | 1 | 2 | 2 |
P9047 |
Albumin (human), 25%, 50ml | Talecris | 13533-0692-16 | Plasbumin-25 | 50 ML | 20 | 1 | 0.4 | 0.4 |
P9047 |
Albumin (human), 25%, 50ml | Talecris | 13533-0692-20 | Plasbumin-25 | 50 ML | 50 | 1 | 1 | 1 |
P9047 |
Albumin (human), 25%, 50ml | Talecris | 13533-0692-71 | Plasbumin-25 | 50 ML | 100 | 1 | 2 | 2 |
Description | Labeler name | NDC | Drug name | Dosage | Package size | Package quantity | Billable units | Billable units / pkg |
---|---|---|---|---|---|---|---|---|
Aminocaproic acid | HENRY SCHEIN, INC. | 00404-9812-20 | Aminocaproic Acid | 250 MG | 20 | 1 | 20 | 20 |
Aminocaproic acid | AMERICAN REGENT | 00517-9191-25 | Aminocaproic Acid | 250 MG | 20 | 25 | 20 | 500 |
Aminocaproic acid | CIVICA INC | 72572-0015-25 | Aminocaproic Acid | 250 MG | 20 | 25 | 20 | 500 |
Aminocaproic acid | PFIZER INC. | 00409-4346-73 | AMINOCAPROIC ACID INJ | 250 MG | 20 | 25 | 20 | 500 |
Aztreonam | BRISTOL-MYERS SQUIBB COMPANY | 00003-2560-16 | AZACTAM | 500 MG | 1 | 10 | 2 | 20 |
Aztreonam | BRISTOL-MYERS SQUIBB COMPANY | 00003-2570-16 | AZACTAM | 500 MG | 1 | 10 | 4 | 40 |
Aztreonam | FRESENIUS KABI | 63323-0401-20 | Aztreonam | 500 MG | 1 | 10 | 2 | 20 |
Aztreonam | FRESENIUS KABI | 63323-0401-24 | Aztreonam | 500 MG | 1 | 10 | 2 | 20 |
Aztreonam | FRESENIUS KABI | 63323-0401-26 | Aztreonam | 500 MG | 1 | 10 | 2 | 20 |
Aztreonam | FRESENIUS KABI | 63323-0402-20 | Aztreonam | 500 MG | 1 | 10 | 4 | 40 |
Aztreonam | FRESENIUS KABI | 63323-0402-24 | Aztreonam | 500 MG | 1 | 10 | 4 | 40 |
Aztreonam | FRESENIUS KABI | 63323-0402-30 | Aztreonam | 500 MG | 1 | 10 | 4 | 40 |
Bumetanide | PFIZER INC. | 00409-1412-04 | Bumetanide | 0.25 MG | 4 | 10 | 4 | 40 |
Bumetanide | PFIZER INC. | 00409-1412-10 | Bumetanide | 0.25 MG | 10 | 10 | 10 | 100 |
Bumetanide | HIKMA PHARMACEUTICALS USA INC. | 00641-6007-10 | Bumetanide | 0.25 MG | 10 | 10 | 10 | 100 |
Bumetanide | HIKMA PHARMACEUTICALS USA INC. | 00641-6008-10 | Bumetanide | 0.25 MG | 4 | 10 | 4 | 40 |
Bumetanide | HIKMA PHARMACEUTICALS USA INC. | 00641-6161-10 | Bumetanide | 0.25 MG | 4 | 10 | 4 | 40 |
Bumetanide | HIKMA PHARMACEUTICALS USA INC. | 00641-6162-10 | Bumetanide | 0.25 MG | 10 | 10 | 10 | 100 |
Bumetanide | FRESENIUS KABI USA | 65219-0570-04 | BUMETANIDE | 0.25 MG | 4 | 10 | 4 | 40 |
Bumetanide | FRESENIUS KABI USA | 65219-0572-10 | BUMETANIDE | 0.25 MG | 10 | 10 | 10 | 100 |
Bumetanide | GLENMARK PHARMACEUTICALS INC., USA | 68462-0469-54 | BUMETANIDE | 0.25 MG | 4 | 10 | 4 | 40 |
Bumetanide | GLENMARK PHARMACEUTICALS INC., USA | 68462-0470-54 | BUMETANIDE | 0.25 MG | 10 | 10 | 10 | 100 |
Bumetanide | ATHENEX PHARMACEUTICAL | 70860-0405-04 | Bumetanide | 0.25 MG | 4 | 10 | 4 | 40 |
Bumetanide | ATHENEX PHARMACEUTICAL | 70860-0406-10 | Bumetanide | 0.25 MG | 10 | 10 | 10 | 100 |
Bumetanide | Novadoz Pharmaceuticals, Llc | 72205-0101-07 | Bumetanide | 0.25 MG | 4 | 10 | 4 | 40 |
Bumetanide | Novadoz Pharmaceuticals, Llc | 72205-0102-07 | Bumetanide | 0.25 MG | 10 | 10 | 10 | 100 |
Bumetanide | CIVICA, INC. | 72572-0040-10 | Bumetanide | 0.25 MG | 4 | 10 | 4 | 40 |
Bumetanide | CIVICA, INC. | 72572-0041-10 | Bumetanide | 0.25 MG | 10 | 10 | 10 | 100 |
Carmustine (Accord) | ACCORD HEALTHCARE INC. | 16729-0545-63 | Carmustine | 100 MG | 1 | 1 | 0.5 | 0.5 |
Carmustine (Accord) | ACCORD HEALTHCARE | 16729-0548-63 | CARMUSTINE | 100 MG | 1 | 1 | 3 | 3 |
Diltiazem Hydrochloride | HIKMA PHARMACEUTICALS USA INC. | 00641-6013-10 | Diltiazem Hcl | 5 MG | 5 | 10 | 5 | 50 |
Diltiazem Hydrochloride | HIKMA PHARMACEUTICALS USA INC. | 00641-6014-10 | Diltiazem Hcl | 5 MG | 10 | 10 | 10 | 100 |
Diltiazem Hydrochloride | HIKMA PHARMACEUTICALS USA INC. | 00641-6015-10 | Diltiazem Hcl | 5 MG | 25 | 10 | 25 | 250 |
Diltiazem Hydrochloride | HIKMA PHARMACEUTICALS USA INC. | 00641-9217-10 | Diltiazem Hcl | 5 MG | 5 | 10 | 5 | 50 |
Diltiazem Hydrochloride | HIKMA PHARMACEUTICALS USA INC. | 00641-9218-10 | Diltiazem Hcl | 5 MG | 10 | 10 | 10 | 100 |
Diltiazem Hydrochloride | HIKMA PHARMACEUTICALS USA INC. | 00641-9219-10 | Diltiazem Hcl | 5 MG | 25 | 10 | 25 | 250 |
Diltiazem Hydrochloride | AKORN | 17478-0937-05 | Diltiazem Hcl | 5 MG | 5 | 10 | 5 | 50 |
Diltiazem Hydrochloride | AKORN | 17478-0937-10 | Diltiazem Hcl | 5 MG | 10 | 10 | 10 | 100 |
Diltiazem Hydrochloride | AKORN | 17478-0937-25 | Diltiazem Hcl | 5 MG | 25 | 10 | 25 | 25 |
Diltiazem Hydrochloride | AKORN | 17478-0937-26 | Diltiazem Hcl | 5 MG | 25 | 10 | 25 | 250 |
Diltiazem Hydrochloride | HEALTHFIRST | 51662-1335-01 | Diltiazem Hcl | 5 MG | 5 | 1 | 5 | 5 |
Diltiazem Hydrochloride | HEALTHFIRST | 51662-1335-02 | Diltiazem Hcl | 5 MG | 5 | 1 | 5 | 5 |
Diltiazem Hydrochloride | HEALTHFIRST | 51662-1457-01 | Diltiazem Hcl | 5 MG | 1 | 1 | 20 | 20 |
Diltiazem Hydrochloride | HEALTHFIRST | 51662-1457-03 | Diltiazem Hcl | 5 MG | 1 | 10 | 20 | 200 |
Diltiazem Hydrochloride | EUGIA US LLC | 55150-0425-10 | Diltiazem HCl | 5 MG | 5 | 10 | 5 | 50 |
Diltiazem Hydrochloride | EUGIA US LLC | 55150-0426-10 | Diltiazem HCl | 5 MG | 10 | 10 | 10 | 100 |
Diltiazem Hydrochloride | EUGIA US LLC | 55150-0427-10 | Diltiazem HCl | 5 MG | 25 | 10 | 25 | 250 |
Diltiazem Hydrochloride | ATHENEX | 70860-0301-05 | Diltiazem HCl | 5 MG | 5 | 10 | 5 | 50 |
Diltiazem Hydrochloride | ATHENEX | 70860-0301-10 | Diltiazem HCl | 5 MG | 10 | 10 | 10 | 100 |
Diltiazem Hydrochloride | ATHENEX | 70860-0301-25 | Diltiazem HCl | 5 MG | 25 | 10 | 25 | 250 |
Doxycycline Hyclate | HIKMA PHARMACEUTICALS USA INC. | 00143-9381-10 | Doxycycline Hyclate | 100 MG | 1 | 10 | 1 | 10 |
Doxycycline Hyclate | HENRY SCHEIN, INC. | 00404-9855-99 | Doxycycline Hyclate | 100 MG | 1 | 1 | 1 | 1 |
Doxycycline Hyclate | FRESENIUS KABI | 63323-0130-11 | Doxycycline Hyclate | 100 MG | 1 | 10 | 1 | 10 |
Doxycycline Hyclate | FRESENIUS KABI | 63323-0130-13 | Doxycycline Hyclate | 100 MG | 1 | 10 | 1 | 10 |
Doxycycline Hyclate | FRESENIUS KABI | 63323-0130-17 | Doxycycline Hyclate | 100 MG | 1 | 10 | 1 | 10 |
Doxycycline Hyclate | PIRAMAL CRITICAL CARE | 66794-0237-41 | Doxycycline Hyclate | 100 MG | 1 | 10 | 1 | 10 |
Doxycycline Hyclate | MYLAN INSTITUTIONAL LLC | 67457-0437-10 | Doxycycline Hyclate | 100 MG | 1 | 10 | 1 | 10 |
Doxycycline Hyclate | ZYDUS PHARMACEUTICALS | 68382-0910-10 | Doxycycline Hyclate | 100 MG | 1 | 10 | 1 | 10 |
Doxycycline Hyclate | HEALTHFIRST | 51662-1402-03 | Doxycyline Hyclate | 100 MG | 1 | 10 | 1 | 10 |
Famotidine | HIKMA PHARMACEUTICALS USA INC. | 00641-6021-10 | Famotidine | 10 MG | 20 | 10 | 20 | 200 |
Famotidine | HIKMA PHARMACEUTICALS USA INC. | 00641-6022-25 | Famotidine | 10 MG | 2 | 25 | 2 | 50 |
Famotidine | HIKMA PHARMACEUTICALS USA INC. | 00641-6023-25 | Famotidine | 10 MG | 4 | 25 | 4 | 100 |
Famotidine | FRESENIUS KABI | 63323-0738-09 | Famotidine | 10 MG | 4 | 10 | 4 | 40 |
Famotidine | FRESENIUS KABI | 63323-0738-20 | Famotidine | 10 MG | 20 | 10 | 20 | 200 |
Famotidine | FRESENIUS KABI | 63323-0739-12 | Famotidine | 10 MG | 2 | 25 | 2 | 50 |
Famotidine | FRESENIUS KABI | 63323-0739-16 | Famotidine | 10 MG | 2 | 25 | 2 | 50 |
Famotidine | MYLAN INSTITUTIONAL LLC | 67457-0448-43 | Famotidine | 10 MG | 4 | 10 | 4 | 40 |
Famotidine | MYLAN INSTITUTIONAL LLC | 67457-0457-20 | Famotidine | 10 MG | 20 | 10 | 20 | 200 |
Famotidine | ATHENEX | 70860-0751-02 | Famotidine | 10 MG | 2 | 25 | 2 | 50 |
Famotidine | ATHENEX | 70860-0753-20 | Famotidine | 10 MG | 20 | 10 | 20 | 200 |
Famotidine | BAXTER | 00338-5197-41 | Famotidine Premixed | 10 MG | 50 | 12 | 2 | 24 |
Flumazenil | HIKMA PHARMACEUTICALS USA INC. | 00143-9683-10 | Flumazenil | 0.1 MG | 10 | 10 | 10 | 100 |
Flumazenil | HIKMA PHARMACEUTICALS USA INC. | 00143-9684-10 | Flumazenil | 0.1 MG | 5 | 10 | 5 | 50 |
Flumazenil | HIKMA PHARMACEUTICALS USA INC. | 00143-9783-10 | Flumazenil | 0.1 MG | 10 | 10 | 10 | 100 |
Flumazenil | HIKMA PHARMACEUTICALS USA INC. | 00143-9784-10 | Flumazenil | 0.1 MG | 5 | 10 | 5 | 50 |
Flumazenil | HENRY SCHEIN, INC. | 00404-9859-10 | Flumazenil | 0.1 MG | 10 | 1 | 10 | 10 |
Flumazenil | HENRY SCHEIN, INC. | 00404-9860-05 | Flumazenil | 0.1 MG | 5 | 1 | 5 | 5 |
Flumazenil | BAXTER | 36000-0148-10 | Flumazenil | 0.1 MG | 5 | 10 | 5 | 50 |
Flumazenil | BAXTER | 36000-0149-10 | Flumazenil | 0.1 MG | 10 | 10 | 10 | 100 |
Flumazenil | HEALTHFIRST | 51662-1253-01 | Flumazenil | 0.1 MG | 10 | 1 | 10 | 10 |
Flumazenil | HEALTHFIRST | 51662-1253-03 | Flumazenil | 0.1 MG | 10 | 10 | 10 | 100 |
Flumazenil | HEALTHFIRST | 51662-1254-01 | Flumazenil | 0.1 MG | 5 | 1 | 5 | 5 |
Flumazenil | HEALTHFIRST | 51662-1254-03 | Flumazenil | 0.1 MG | 5 | 10 | 5 | 50 |
Flumazenil | FRESENIUS KABI | 63323-0424-05 | Flumazenil | 0.1 MG | 5 | 10 | 5 | 50 |
Flumazenil | FRESENIUS KABI | 63323-0424-10 | Flumazenil | 0.1 MG | 10 | 1 | 10 | 10 |
Folic Acid | X-GEN PHARMACEUTICALS INC | 39822-1100-01 | Folic Acid | 5 MG | 10 | 1 | 10 | 10 |
Folic Acid | FRESENIUS KABI | 63323-0184-10 | Folic Acid | 5 MG | 10 | 1 | 10 | 10 |
Furosemide (Phlow Corporation) | PHLOW CORPORATION | 81565-0201-02 | Furosemide | 20 MG | 2 | 25 | 1 | 25 |
Glycopyrrolate injection | AMERICAN REGENT | 00517-4601-25 | Glycopyrrolate | 0.2 MG | 1 | 25 | 1 | 25 |
Glycopyrrolate injection | AMERICAN REGENT | 00517-4602-25 | Glycopyrrolate | 0.2 MG | 2 | 25 | 2 | 50 |
Glycopyrrolate injection | AMERICAN REGENT | 00517-4605-25 | Glycopyrrolate | 0.2 MG | 5 | 25 | 5 | 125 |
Glycopyrrolate injection | AMERICAN REGENT | 00517-4620-25 | Glycopyrrolate | 0.2 MG | 20 | 25 | 20 | 500 |
Glycopyrrolate injection | Meitheal Pharmaceuticals Inc. | 71288-0414-04 | Glycopyrrolate | 0.2 MG | 2 | 25 | 2 | 50 |
Glycopyrrolate injection | Meitheal Pharmaceuticals Inc. | 71288-0415-06 | Glycopyrrolate | 0.2 MG | 5 | 25 | 5 | 125 |
Glycopyrrolate injection (Fresenius Kabi) | Fresenius Kabi USA, LLC | 76045-0023-30 | Glycopyrrolate | 0.2 MG | 3 | 10 | 3 | 30 |
Glycopyrrolate injection | FRESENIUS KABI | 63323-0578-11 | Glycopyrrolate (injection) | 0.2 MG | 1 | 25 | 1 | 25 |
Glycopyrrolate injection | FRESENIUS KABI | 63323-0578-12 | Glycopyrrolate (injection) | 0.2 MG | 2 | 25 | 2 | 50 |
Glycopyrrolate injection | MEITHEAL PHARMACEUTICALS | 71288-0414-03 | Glycopyrrolate (injection) | 0.2 MG | 1 | 25 | 1 | 25 |
Glycopyrrolate injection | HIKMA PHARMACEUTICALS USA INC. | 00143-9584-10 | Glycopyrrolate INJECTION | 0.2 MG | 20 | 10 | 20 | 200 |
Glycopyrrolate injection | HIKMA PHARMACEUTICALS USA INC. | 00143-9585-25 | Glycopyrrolate INJECTION | 0.2 MG | 5 | 25 | 5 | 125 |
Glycopyrrolate injection | HIKMA PHARMACEUTICALS USA INC. | 00143-9586-25 | Glycopyrrolate INJECTION | 0.2 MG | 2 | 25 | 2 | 50 |
Glycopyrrolate injection | HIKMA PHARMACEUTICALS USA INC. | 00143-9587-25 | Glycopyrrolate INJECTION | 0.2 MG | 1 | 25 | 1 | 25 |
Glycopyrrolate injection | HIKMA PHARMACEUTICALS USA INC. | 00143-9679-10 | Glycopyrrolate INJECTION | 0.2 MG | 20 | 10 | 20 | 200 |
Glycopyrrolate injection | HIKMA PHARMACEUTICALS USA INC. | 00143-9680-25 | Glycopyrrolate INJECTION | 0.2 MG | 5 | 25 | 5 | 125 |
Glycopyrrolate injection | HIKMA PHARMACEUTICALS USA INC. | 00143-9681-25 | Glycopyrrolate INJECTION | 0.2 MG | 2 | 25 | 2 | 50 |
Glycopyrrolate injection | HIKMA PHARMACEUTICALS USA INC. | 00143-9682-25 | Glycopyrrolate INJECTION | 0.2 MG | 1 | 25 | 1 | 25 |
Glycopyrrolate injection | HENRY SCHEIN, INC. | 00404-9867-01 | Glycopyrrolate Injection | 0.2 MG | 1 | 1 | 1 | 1 |
Glycopyrrolate injection | HENRY SCHEIN, INC. | 00404-9868-20 | Glycopyrrolate Injection | 0.2 MG | 20 | 1 | 20 | 20 |
Glycopyrrolate injection | HENRY SCHEIN, INC. | 00404-9869-02 | Glycopyrrolate Injection | 0.2 MG | 2 | 1 | 2 | 2 |
Glycopyrrolate injection | HENRY SCHEIN, INC. | 00404-9870-05 | Glycopyrrolate Injection | 0.2 MG | 5 | 1 | 5 | 5 |
Glycopyrrolate injection | SANDOZ | 00781-3825-96 | Glycopyrrolate Injection | 0.2 MG | 1 | 25 | 1 | 25 |
Glycopyrrolate injection | SANDOZ | 00781-3827-96 | Glycopyrrolate Injection | 0.2 MG | 2 | 25 | 2 | 50 |
Glycopyrrolate injection | SANDOZ | 00781-3829-96 | Glycopyrrolate Injection | 0.2 MG | 5 | 25 | 5 | 125 |
Glycopyrrolate injection | SANDOZ | 00781-3831-95 | Glycopyrrolate Injection | 0.2 MG | 20 | 10 | 20 | 200 |
Glycopyrrolate injection | A-S MEDICATION SOLUTIONS | 50090-5226-00 | Glycopyrrolate Injection | 0.2 MG | 1 | 25 | 1 | 25 |
Glycopyrrolate injection | HEALTHFIRST | 51662-1487-01 | Glycopyrrolate Injection | 0.2 MG | 1 | 1 | 1 | 1 |
Glycopyrrolate injection | HEALTHFIRST | 51662-1487-03 | Glycopyrrolate Injection | 0.2 MG | 1 | 25 | 1 | 25 |
Glycopyrrolate injection | HEALTHFIRST | 51662-1554-03 | Glycopyrrolate Injection | 0.2 MG | 2 | 25 | 2 | 50 |
Glycopyrrolate injection | HEALTHFIRST | 51662-1601-01 | Glycopyrrolate Injection | 0.2 MG | 5 | 1 | 5 | 5 |
Glycopyrrolate injection | HEALTHFIRST | 51662-1601-03 | Glycopyrrolate Injection | 0.2 MG | 5 | 25 | 5 | 125 |
Glycopyrrolate injection | AUROMEDICS PHARMA LLC | 55150-0292-01 | Glycopyrrolate Injection | 0.2 MG | 1 | 25 | 1 | 25 |
Glycopyrrolate injection | AUROMEDICS PHARMA LLC | 55150-0293-02 | Glycopyrrolate Injection | 0.2 MG | 2 | 25 | 2 | 50 |
Glycopyrrolate injection | AUROMEDICS PHARMA LLC | 55150-0294-05 | Glycopyrrolate Injection | 0.2 MG | 5 | 25 | 5 | 125 |
Glycopyrrolate injection | AUROMEDICS PHARMA LLC | 55150-0295-20 | Glycopyrrolate Injection | 0.2 MG | 20 | 25 | 20 | 500 |
Glycopyrrolate injection | APOTEX CORP. | 60505-6179-05 | Glycopyrrolate Injection | 0.2 MG | 1 | 25 | 1 | 25 |
Glycopyrrolate injection | APOTEX CORP. | 60505-6180-05 | Glycopyrrolate Injection | 0.2 MG | 2 | 25 | 2 | 50 |
Glycopyrrolate injection | APOTEX CORP. | 60505-6181-05 | Glycopyrrolate Injection | 0.2 MG | 5 | 25 | 5 | 125 |
Glycopyrrolate injection | APOTEX CORP. | 60505-6182-04 | Glycopyrrolate Injection | 0.2 MG | 20 | 10 | 20 | 200 |
Glycopyrrolate injection | FRESENIUS KABI | 63323-0578-01 | Glycopyrrolate Injection | 0.2 MG | 1 | 25 | 1 | 25 |
Glycopyrrolate injection | FRESENIUS KABI | 63323-0578-02 | Glycopyrrolate Injection | 0.2 MG | 2 | 25 | 2 | 50 |
Glycopyrrolate injection | FRESENIUS KABI | 63323-0578-05 | Glycopyrrolate Injection | 0.2 MG | 5 | 25 | 5 | 125 |
Glycopyrrolate injection | PIRAMAL CRITICAL CARE | 66794-0202-42 | Glycopyrrolate Injection | 0.2 MG | 1 | 25 | 1 | 25 |
Glycopyrrolate injection | PIRAMAL CRITICAL CARE | 66794-0203-42 | Glycopyrrolate Injection | 0.2 MG | 2 | 25 | 2 | 50 |
Glycopyrrolate injection | PIRAMAL CRITICAL CARE | 66794-0204-42 | Glycopyrrolate Injection | 0.2 MG | 5 | 25 | 5 | 125 |
Glycopyrrolate injection | PIRAMAL CRITICAL CARE | 66794-0205-41 | Glycopyrrolate Injection | 0.2 MG | 20 | 10 | 20 | 200 |
Glycopyrrolate injection | AMERICAN HEALTH PACKAGING | 68001-0351-60 | Glycopyrrolate Injection | 0.2 MG | 1 | 25 | 1 | 25 |
Glycopyrrolate injection | AMERICAN HEALTH PACKAGING | 68001-0352-71 | Glycopyrrolate Injection | 0.2 MG | 2 | 25 | 2 | 50 |
Glycopyrrolate injection | AMERICAN HEALTH PACKAGING | 68001-0353-72 | Glycopyrrolate Injection | 0.2 MG | 5 | 25 | 5 | 125 |
Glycopyrrolate injection | AMNEAL BIOSCIENCES | 70121-1394-05 | Glycopyrrolate Injection | 0.2 MG | 1 | 25 | 1 | 25 |
Glycopyrrolate injection | AMNEAL BIOSCIENCES | 70121-1395-05 | Glycopyrrolate Injection | 0.2 MG | 2 | 25 | 2 | 50 |
Glycopyrrolate injection | AMNEAL BIOSCIENCES | 70121-1396-05 | Glycopyrrolate Injection | 0.2 MG | 5 | 25 | 5 | 125 |
Glycopyrrolate injection | AMNEAL BIOSCIENCES | 70121-1397-07 | Glycopyrrolate Injection | 0.2 MG | 20 | 10 | 20 | 200 |
Glycopyrrolate injection | AMNEAL PHARMACEUTICALS INC | 70121-1698-07 | Glycopyrrolate Injection | 0.2 MG | 1 | 10 | 1 | 10 |
Glycopyrrolate injection | AMNEAL PHARMACEUTICALS INC | 70121-1699-07 | Glycopyrrolate Injection | 0.2 MG | 2 | 10 | 2 | 20 |
Glycopyrrolate injection | MEITHEAL PHARMACEUTICALS | 71288-0415-21 | Glycopyrrolate Injection | 0.2 MG | 20 | 10 | 20 | 200 |
Glycopyrrolate injection | BE PHARMACEUTICALS, INC. | 71839-0123-25 | Glycopyrrolate INJECTION | 0.2 MG | 1 | 25 | 1 | 25 |
Glycopyrrolate injection | BE PHARMACEUTICALS, INC. | 71839-0124-25 | Glycopyrrolate INJECTION | 0.2 MG | 2 | 25 | 2 | 50 |
Glycopyrrolate injection | BE PHARMACEUTICALS, INC. | 71839-0125-25 | Glycopyrrolate INJECTION | 0.2 MG | 5 | 25 | 5 | 125 |
Glycopyrrolate injection | CIVICA INC | 72572-0225-25 | Glycopyrrolate Injection | 0.2 MG | 1 | 25 | 1 | 25 |
Glycopyrrolate injection | CIVICA INC | 72572-0226-25 | Glycopyrrolate Injection | 0.2 MG | 1 | 25 | 1 | 25 |
Glycopyrrolate injection | FRESENIUS KABI | 76045-0203-10 | Glycopyrrolate Injection | 0.2 MG | 1 | 24 | 1 | 24 |
Glycopyrrolate injection | FRESENIUS KABI | 76045-0203-20 | Glycopyrrolate Injection | 0.2 MG | 2 | 24 | 2 | 48 |
Metoprolol Tartrate | HIKMA PHARMACEUTICALS USA INC. | 00143-9873-25 | METOPROLOL INJ | 1 MG | 5 | 25 | 5 | 125 |
Metoprolol Tartrate | HIKMA PHARMACEUTICALS USA INC. | 00143-9660-10 | Metoprolol Tartrate | 1 MG | 5 | 10 | 5 | 50 |
Metoprolol Tartrate | PFIZER INC. | 00409-1778-05 | Metoprolol Tartrate | 1 MG | 5 | 10 | 5 | 50 |
Metoprolol Tartrate | HOSPIRA, INC. | 00409-2016-10 | Metoprolol Tartrate | 1 MG | 5 | 10 | 5 | 50 |
Metoprolol Tartrate | BAXTER | 36000-0033-10 | Metoprolol Tartrate | 1 MG | 5 | 10 | 5 | 50 |
Metoprolol Tartrate | ALVOGEN | 47781-0587-17 | Metoprolol Tartrate | 1 MG | 5 | 10 | 5 | 50 |
Metoprolol Tartrate | HEALTHFIRST | 51662-1478-01 | Metoprolol Tartrate | 1 MG | 5 | 1 | 5 | 5 |
Metoprolol Tartrate | FRESENIUS KABI | 63323-0660-05 | METOPROLOL TARTRATE | 1 MG | 5 | 10 | 5 | 50 |
Metoprolol Tartrate | FOSUN PHARMA USA | 72266-0122-05 | Metoprolol Tartrate | 1 MG | 5 | 5 | 5 | 25 |
Metoprolol Tartrate | FOSUN PHARMA | 72266-0122-25 | Metoprolol Tartrate | 1 MG | 5 | 25 | 5 | 125 |
Metoprolol Tartrate | CIVICA INC | 72572-0420-10 | Metoprolol Tartrate | 1 MG | 5 | 10 | 5 | 50 |
Metoprolol Tartrate | ALMAJECT | 72611-0740-10 | Metoprolol Tartrate | 1 MG | 5 | 10 | 5 | 50 |
Rifampin | FRESENIUS KABI | 63323-0351-20 | Rifampin | 600 MG | 1 | 1 | 1 | 1 |
Rifampin | MYLAN INSTITUTIONAL LLC | 67457-0445-60 | Rifampin | 600 MG | 1 | 1 | 1 | 1 |
Sodium Chloride, Hypertonic (3% - 5% infusion) | B. BRAUN MEDICAL INC. | 00264-7805-10 | Sodium Chloride | 250 CC | 500 | 24 | 2 | 48 |
Sodium Chloride, Hypertonic (3% - 5% infusion) | B. BRAUN MEDICAL INC. | 00264-7806-10 | Sodium Chloride | 250 CC | 500 | 24 | 2 | 48 |
Sodium Chloride, Hypertonic (3% - 5% infusion) | BAXTER | 00338-0054-03 | Sodium Chloride | 250 CC | 500 | 1 | 2 | 2 |
Sodium Chloride, Hypertonic (3% - 5% infusion) | BAXTER | 00338-0056-03 | Sodium Chloride | 250 CC | 500 | 1 | 2 | 2 |
Sulfamethoxazole-Trimethoprim | SICOR PHARMACEUTICALS, INC. | 00703-9503-03 | Sulfamethoxazole-Trimethoprim | 400-80 MG | 50 | 10 | 10 | 100 |
Sulfamethoxazole-Trimethoprim | SICOR PHARMACEUTICALS, INC. | 00703-9514-03 | Sulfamethoxazole-Trimethoprim | 400-80 MG | 100 | 10 | 20 | 200 |
Sulfamethoxazole-Trimethoprim | SICOR PHARMACEUTICALS, INC. | 00703-9514-93 | Sulfamethoxazole-Trimethoprim | 400-80 MG | 10 | 10 | 2 | 20 |
Sulfamethoxazole-Trimethoprim | SICOR PHARMACEUTICALS, INC. | 00703-9526-01 | Sulfamethoxazole-Trimethoprim | 400-80 MG | 30 | 1 | 6 | 6 |
Sulfamethoxazole-Trimethoprim | MYLAN INSTITUTIONAL LLC | 67457-0778-05 | Sulfamethoxazole-Trimethoprim | 400-80 MG | 5 | 10 | 1 | 10 |
Sulfamethoxazole-Trimethoprim | MYLAN INSTITUTIONAL LLC | 67457-0779-30 | Sulfamethoxazole-Trimethoprim | 400-80 MG | 30 | 1 | 6 | 6 |
Sulfamethoxazole-Trimethoprim | MYLAN INSTITUTIONAL LLC | 67457-0921-05 | Sulfamethoxazole-Trimethoprim | 400-80 MG | 5 | 10 | 1 | 10 |
Sulfamethoxazole-Trimethoprim | MYLAN INSTITUTIONAL LLC | 67457-0922-30 | Sulfamethoxazole-Trimethoprim | 400-80 MG | 30 | 1 | 6 | 6 |
Glucarpidase | BTG INTERNATIONAL INC. | 50633-0210-11 | Voraxaze | 10 UNITS | 1 | 1 | 100 | 100 |
HCPCS | Description | Labeler name | NDC | Drug name | Dosage | Package size | Package quantity | Billable units | Billable units / pkg |
---|---|---|---|---|---|---|---|---|---|
A9513 |
Lutetium Lu 177 dotatat ther | ADVANCED ACCELERATOR APPLICATIONS | 69488-0003-01 | LUTATHERA | 1 MCI | 20 | 1 | 200 | 200 |
A9543 |
Y90 ibritumomab, rx | SPECTRUM PHARMACEUTICALS | 68152-0103-03 | ZEVALIN Y-90 | UP TO 40 millicuries | 1 | 1 | 1 | 1 |
A9543 |
Y90 ibritumomab, rx | ACROTECH BIOPHARMA | 72893-0007-04 | ZEVALIN Y-90 | UP TO 40 millicuries | 1 | 1 | 1 | 1 |
A9590 |
Iodine i-131 iobenguane 1mci | PROGENICS PHARMACEUTICALS, INC. | 71258-0015-22 | AZEDRA therapeutic | 1 mCi | 1 | 1 | 1 | 1 |
A9592 |
Copper cu 64 dotatate diag | CURIUM US LLC | 69945-0064-01 | Detectnet | 1 mCi | 4 | 1 | 4 | 4 |
A9593 |
Gallium ga-68 psma-11 ucsf | UCSF RADIOPHARMACEUTICAL FACILITY | 24275-0525-01 | Gallium Ga 68 PSMA (UCSF) | 1 mCi | 11 | 1 | 1 | 1 |
A9594 |
Gallium ga-68 psma-11, ucla | UCLA BIOMEDICAL CYCLOTRON | 76394-2642-03 | Gallium Ga 68 PSMA (UCLA) | 1 mCi | 12 | 1 | 1 | 1 |
A9595 |
Piflu f-18, dia 1 millicurie | PROGENICS PHARMACEUTICALS, INC | 71258-0022-00 | Pylarify | 1 millicurie | 1 | 1 | 9 | 9 |
A9596 |
Gallium illuccix 1 millicure | TELIX PHARMACEUTICALS, INC. | 74725-0100-25 | ILLUCCIX | 1 mCi | 1 | 1 | 1 | 1 |
A9596 |
Gallium illuccix 1 millicure | TELIX PHARMACEUTICALS, INC. | 74725-0100-64 | ILLUCCIX | 1 mCi | 1 | 1 | 1 | 1 |
A9600 |
Sr89 strontium | QBIOMED INC | 72928-0089-01 | Strontium Chloride Sr 89 | PER MILLICURIE | 4 | 1 | 1 | 4 |
A9600 |
Sr89 strontium | GE HEALTHCARE | 17156-0524-01 | METASTRON | PER MILLICURIE | 4 | 1 | 4 | 4 |
A9602 |
Fluorodopa f-18 diag per mci | THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH | 13267-0346-57 | Fluorodopa F18 | 1 mCi | 1 | 1 | 1 | 1 |
A9604 |
Sm 153 lexidronam | LANTHEUS MEDICAL IMAGING, INC. | 11994-0016-01 | QUADRAMET | up to 150 millicuries | 3 | 1 | 1 | 1 |
A9606 |
Radium Ra223 dichloride ther | BAYER HEALTHCARE PHARMACEUTICALS INC. | 50419-0208-01 | Xofigo | 1 mCi | 6 | 1 | 1 | 1 |
A9607 |
Lutetium lu 177 vipivotide | ADVANCED ACCELERATOR APPLICATIONS USA, INC | 69488-0010-61 | PLUVICTO | 1 mCi | 1 | 1 | 1 | 1 |
A9800 |
Gallium locametz 1 millicuri | ADVANCED ACCELERATOR APPLICATIONS USA, INC | 69488-0017-61 | LOCAMETZ | 1 mCi | 1 | 1 | 1 | 1 |
C9047 |
Injection, caplacizumab-yhdp | GENZYME CORPORATION | 58468-0225-01 | Cablivi | 1 MG | 1 | 1 | 11 | 11 |
C9088 |
Instill, bupivac and meloxic | HERON THERAPEUTICS | 47426-0301-02 | Zynrelef | 1 mg - 0.03 mg | 14 | 1 | 400 | 400 |
C9088 |
Instill, bupivac and meloxic | HERON THERAPEUTICS, INC. | 47426-0302-02 | Zynrelef | 1 mg - 0.03 mg | 10.5 | 1 | 300 | 300 |
C9088 |
Instill, bupivac and meloxic | HERON THERAPEUTICS | 47426-0303-01 | Zynrelef | 1 mg - 0.03 mg | 7 | 1 | 200 | 200 |
C9088 |
Instill, bupivac and meloxic | HERON THERAPEUTICS, INC. | 47426-0304-01 | Zynrelef | 1 mg - 0.03 mg | 2.3 | 1 | 60 | 60 |
C9089 |
Bupivacaine implant, 1 mg | INNOCOLL PHARMACEUTICALS LIMITED | 51715-0100-04 | Xaracoll | 1 mg | 1 | 12 | 100 | 1200 |
C9089 |
Bupivacaine implant, 1 mg | INNOCOLL PHARMACEUTICALS LIMITED | 51715-0100-10 | Xaracoll | 1 mg | 1 | 30 | 100 | 3000 |
C9101 |
Inj, oliceridine 0.1 mg | TREVENA, INC. | 71308-0011-10 | Olinvyk | 0.1 MG | 1 | 10 | 10 | 100 |
C9101 |
Inj, oliceridine 0.1 mg | TREVENA, INC. | 71308-0021-10 | Olinvyk | 0.1 MG | 2 | 10 | 20 | 200 |
C9101 |
Inj, oliceridine 0.1 mg | TREVENA, INC. | 71308-0301-10 | Olinvyk | 0.1 MG | 30 | 10 | 300 | 3000 |
C9144 |
Inj, bupivacaine (posimir) | INNOCOLL PHARMACEUTICALS | 51715-0660-10 | Posimir | 1 MG | 5 | 10 | 660 | 6600 |
C9145 |
Inj, aponvie, 1 mg | HERON THERAPEUTICS, INC. | 47426-0401-10 | APONVIE | 1 MG | 4.4 | 10 | 32 | 320 |
C9152 |
Inj, abilify asimtufii, 1 mg | OTSUKA AMERICA PHARMACEUTICALS, INC | 59148-0102-80 | Abilify Asimtufii | 1 MG | 2.4 | 1 | 720 | 720 |
C9152 |
Inj, abilify asimtufii, 1 mg | OTSUKA AMERICA PHARMACEUTICALS, INC | 59148-0114-80 | Abilify Asimtufii | 1 MG | 3.2 | 1 | 960 | 960 |
C9153 |
Inj, amisulpride, 1 mg | ACACIA PHARMA, INC. | 71390-0125-20 | BARHEMSYS | 1 MG | 2 | 10 | 5 | 50 |
C9153 |
Inj, amisulpride, 1 mg | ACACIA PHARMA, INC. | 71390-0125-50 | BARHEMSYS | 1 MG | 4 | 10 | 10 | 100 |
C9154 |
Inj buprenorph (brixadi) 1mg | BRAEBURN INC. | 58284-0228-01 | Brixadi (monthly dosing) | 1 MG | 0.36 | 1 | 128 | 128 |
C9154 |
Inj buprenorph (brixadi) 1mg | BRAEBURN INC. | 58284-0264-01 | Brixadi (monthly dosing) | 1 MG | 0.18 | 1 | 64 | 64 |
C9154 |
Inj buprenorph (brixadi) 1mg | BRAEBURN INC. | 58284-0296-01 | Brixadi (monthly dosing) | 1 MG | 0.27 | 1 | 96 | 96 |
C9154 |
Inj buprenorph (brixadi) 1mg | BRAEBURN INC. | 58284-0208-01 | Brixadi (weekly dosing) | 1 MG | 0.16 | 1 | 8 | 8 |
C9154 |
Inj buprenorph (brixadi) 1mg | BRAEBURN INC. | 58284-0216-01 | Brixadi (weekly dosing) | 1 MG | 0.32 | 1 | 16 | 16 |
C9154 |
Inj buprenorph (brixadi) 1mg | BRAEBURN INC. | 58284-0224-01 | Brixadi (weekly dosing) | 1 MG | 0.48 | 1 | 24 | 24 |
C9154 |
Inj buprenorph (brixadi) 1mg | BRAEBURN INC. | 58284-0232-01 | Brixadi (weekly dosing) | 1 MG | 0.64 | 1 | 32 | 32 |
C9155 |
Inj epcoritamab-bysp, 0.1 mg | GENMAB US, INC. | 82705-0002-01 | EPKINLY | 0.16 MG | 0.8 | 1 | 25 | 25 |
C9155 |
Inj epcoritamab-bysp, 0.1 mg | GENMAB US, INC. | 82705-0010-01 | EPKINLY | 0.16 MG | 0.8 | 1 | 300 | 300 |
C9157 |
Inj, tofersen, 1 mg | BIOGEN MA INC. | 64406-0109-01 | QALSODY | 1 MG | 15 | 1 | 100 | 100 |
C9158 |
Inj, uzedy, 1 mg | TEVA NEUROSCIENCE, INC. | 51759-0305-10 | UZEDY | 1 MG | 0.14 | 1 | 50 | 50 |
C9158 |
Inj, uzedy, 1 mg | TEVA NEUROSCIENCE, INC. | 51759-0410-10 | UZEDY | 1 MG | 0.21 | 1 | 75 | 75 |
C9158 |
Inj, uzedy, 1 mg | TEVA NEUROSCIENCE, INC. | 51759-0520-10 | UZEDY | 1 MG | 0.28 | 1 | 100 | 100 |
C9158 |
Inj, uzedy, 1 mg | TEVA NEUROSCIENCE, INC. | 51759-0630-10 | UZEDY | 1 MG | 0.35 | 1 | 125 | 125 |
C9158 |
Inj, uzedy, 1 mg | TEVA NEUROSCIENCE, INC. | 51759-0740-10 | UZEDY | 1 MG | 0.42 | 1 | 150 | 150 |
C9158 |
Inj, uzedy, 1 mg | TEVA NEUROSCIENCE, INC. | 51759-0850-10 | UZEDY | 1 MG | 0.56 | 1 | 200 | 200 |
C9158 |
Inj, uzedy, 1 mg | TEVA NEUROSCIENCE, INC. | 51759-0960-10 | UZEDY | 1 MG | 0.7 | 1 | 250 | 250 |
C9248 |
Inj, clevidipine butyrate | CHIESI USA, INC. | 10122-0610-10 | CLEVIPREX | 1 MG | 50 | 10 | 25 | 250 |
C9248 |
Inj, clevidipine butyrate | CHIESI USA, INC. | 10122-0611-10 | CLEVIPREX | 1 MG | 100 | 10 | 50 | 500 |
C9250 |
Artiss fibrin sealant | BAXTER | 00338-9637-01 | Artiss | 2 ML | 2 | 1 | 1 | 1 |
C9250 |
Artiss fibrin sealant | BAXTER | 00338-9639-01 | Artiss | 2 ML | 4 | 1 | 2 | 2 |
C9250 |
Artiss fibrin sealant | BAXTER | 00338-9641-01 | Artiss | 2 ML | 10 | 1 | 5 | 5 |
C9257 |
Bevacizumab injection | GENENTECH, INC. | 50242-0060-01 | Avastin | 0.25 MG | 4 | 1 | 400 | 400 |
C9257 |
Bevacizumab injection | GENENTECH, INC. | 50242-0060-10 | Avastin | 0.25 MG | 4 | 10 | 400 | 4000 |
C9257 |
Bevacizumab injection | GENENTECH, INC. | 50242-0061-01 | Avastin | 0.25 MG | 16 | 1 | 1600 | 1600 |
C9257 |
Bevacizumab injection | GENENTECH, INC. | 50242-0061-10 | Avastin | 0.25 MG | 16 | 10 | 1600 | 16000 |
C9290 |
Inj, bupivacaine liposome | PACIRA PHARMACEUTICALS | 65250-0133-04 | EXPAREL | 1 MG | 10 | 4 | 133 | 532 |
C9290 |
Inj, bupivacaine liposome | PACIRA PHARMACEUTICALS | 65250-0133-09 | EXPAREL | 1 MG | 10 | 10 | 133 | 1330 |
C9290 |
Inj, bupivacaine liposome | PACIRA PHARMACEUTICALS | 65250-0266-04 | EXPAREL | 1 MG | 20 | 4 | 266 | 1064 |
C9290 |
Inj, bupivacaine liposome | PACIRA PHARMACEUTICALS | 65250-0266-09 | EXPAREL | 1 MG | 20 | 10 | 266 | 2660 |
C9460 |
Injection, cangrelor | CHIESI USA, INC. | 10122-0620-10 | KENGREAL | 1 MG | 1 | 10 | 50 | 500 |
C9482 |
Sotalol hydrochloride IV | ALTATHERA PHARMACEUTICALS | 69724-0112-10 | Sotalol | 1MG | 10 | 1 | 150 | 150 |
C9488 |
Conivaptan HCL | CUMBERLAND PHARMACEUTICALS | 66220-0160-10 | VAPRISOL | 1 MG | 100 | 1 | 20 | 20 |
J0135 |
Adalimumab injection | ABBVIE US, LLC | 00074-3799-02 | Humira | 20 MG | 0.8 | 2 | 2 | 4 |
J0135 |
Adalimumab injection | ABBVIE US, LLC | 00074-4339-02 | Humira | 20 MG | 0.8 | 2 | 2 | 4 |
J0135 |
Adalimumab injection | ABBVIE US, LLC | 00074-4339-06 | Humira | 20 MG | 0.8 | 6 | 2 | 12 |
J0135 |
Adalimumab injection | ABBVIE US, LLC | 00074-4339-07 | Humira | 20 MG | 0.8 | 4 | 2 | 8 |
J0208 |
Inj sodium thiosulfate 100mg | FENNEC PHARMACEUTICALS INC. | 73077-0010-01 | Sodium Thiosulfate | 100 MG | 100 | 1 | 125 | 125 |
J0287 |
Amphotericin b lipid complex | LEADIANT BIOSCIENCES, INC. | 57665-0101-41 | Abelcet | 10 MG | 20 | 1 | 10 | 10 |
J0349 |
Inj, rezafungin, 1 mg | Melinta Therapeutics, LLC | 70842-0240-01 | REZZAYO | 1 MG | 1 | 1 | 200 | 200 |
J0470 |
Dimecaprol injection | AKORN | 17478-0526-03 | Bal In Oil | 100 MG | 3 | 10 | 3 | 30 |
J0570 |
Buprenorphine implant 74.2mg | TITAN PHARMACEUTICALS | 52440-0100-14 | PROBUPHINE SYSTEM KIT | 74.2 MG | 1 | 4 | 1 | 4 |
J0641 |
Levoleucovorin injection | HIKMA PHARMACEUTICALS USA INC. | 00143-9558-01 | Levoleucovorin Calcium | 0.5 MG | 1 | 1 | 100 | 100 |
J0641 |
Levoleucovorin injection | SANDOZ | 00781-3201-94 | Levoleucovorin Calcium | 0.5 MG | 17.5 | 1 | 350 | 350 |
J0641 |
Levoleucovorin injection | DR. REDDY'S LABORATORIES, INC. | 43598-0771-11 | Levoleucovorin Calcium | 0.5 MG | 17.5 | 1 | 350 | 350 |
J0641 |
Levoleucovorin injection | DR. REDDY'S LABORATORIES, INC. | 43598-0773-11 | Levoleucovorin Calcium | 0.5 MG | 25 | 1 | 500 | 500 |
J0641 |
Levoleucovorin injection | INGENUS PHARMACEUTICALS, LLC | 50742-0494-17 | Levoleucovorin Calcium | 0.5 MG | 17.5 | 1 | 350 | 350 |
J0641 |
Levoleucovorin injection | INGENUS PHARMACEUTICALS, LLC | 50742-0495-25 | Levoleucovorin Calcium | 0.5 MG | 25 | 1 | 500 | 500 |
J0641 |
Levoleucovorin injection | AMNEAL BIOSCIENCES | 70121-1099-01 | Levoleucovorin Calcium | 0.5 MG | 1 | 1 | 100 | 100 |
J0641 |
Levoleucovorin injection | AMNEAL BIOSCIENCES | 70121-1572-01 | Levoleucovorin Calcium | 0.5 MG | 17.5 | 1 | 350 | 350 |
J0641 |
Levoleucovorin injection | MEITHEAL PHARMACEUTICALS | 71288-0104-10 | Levoleucovorin Calcium | 0.5 MG | 1 | 1 | 100 | 100 |
J0641 |
Levoleucovorin injection | Meitheal Pharmaceuticals, Inc. | 71288-0105-18 | Levoleucovorin Calcium | 0.5 MG | 17.5 | 1 | 350 | 350 |
J0641 |
Levoleucovorin injection | FOSUN PHARMA | 72266-0120-01 | Levoleucovorin Calcium | 0.5 MG | 17.5 | 1 | 350 | 350 |
J0716 |
Centruroides immune f(ab) | RARE DISEASE THERAPEUTICS, INC. | 66621-0150-02 | ANASCORP | UP TO 120MG | 1 | 1 | 1 | 1 |
J0802 |
Inj. (ani), up to 40 units | Ani Pharmaceuticals, Inc. | 62559-0860-15 | Cortrophin Gel | UP TO 40 UNITS | 5 | 1 | 10 | 10 |
J0802 |
Inj. (ani), up to 40 units | ANI Pharmaceuticals, Inc. | 62559-0860-11 | PURIFIED CORTROPHIN GEL | UP TO 40 UNITS | 1 | 1 | 2 | 2 |
J0879 |
Difelikefalin, esrd on dialy | Vifor | 59353-0065-01 | Korsuva | 0.1 mcg | 1.3 | 1 | 65 | 650 |
J0879 |
Difelikefalin, esrd on dialy | Vifor | 59353-0065-12 | Korsuva | 0.1 mcg | 1.3 | 1 | 65 | 7800 |
J0884 |
Argatroban esrd dialysis 1mg | NOVARTIS PHARMACEUTICALS CORPORATION | 00078-0930-61 | Argatroban | 1 MG | 2.5 | 1 | 250 | 250 |
J0884 |
Argatroban esrd dialysis 1mg | HIKMA PHARMACEUTICALS USA INC. | 00143-9288-01 | Argatroban | 1 MG | 2.5 | 1 | 250 | 250 |
J0884 |
Argatroban esrd dialysis 1mg | HIKMA PHARMACEUTICALS USA INC. | 00143-9377-01 | Argatroban | 1 MG | 50 | 1 | 50 | 50 |
J0884 |
Argatroban esrd dialysis 1mg | HIKMA PHARMACEUTICALS USA INC. | 00143-9559-01 | ARGATROBAN | 1 MG | 50 | 1 | 50 | 50 |
J0884 |
Argatroban esrd dialysis 1mg | HIKMA PHARMACEUTICALS USA INC. | 00143-9674-01 | Argatroban | 1 MG | 2.5 | 1 | 250 | 250 |
J0884 |
Argatroban esrd dialysis 1mg | PFIZER INC. | 00409-1140-01 | Argatroban | 1 MG | 2.5 | 1 | 250 | 250 |
J0884 |
Argatroban esrd dialysis 1mg | SAGENT PHARMACEUTICALS INC | 25021-0414-50 | ARGATROBAN | 1 MG | 50 | 1 | 50 | 50 |
J0884 |
Argatroban esrd dialysis 1mg | PAR PHARMACEUTICAL, INC | 42023-0182-01 | Argatroban | 1 MG | 2.5 | 1 | 250 | 250 |
J0884 |
Argatroban esrd dialysis 1mg | PAR PHARMACEUTICAL | 42023-0182-89 | ARGATROBAN | 1 MG | 2.5 | 1 | 250 | 250 |
J0884 |
Argatroban esrd dialysis 1mg | FRESENIUS KABI | 63323-0526-03 | Argatroban | 1 MG | 2.5 | 1 | 250 | 250 |
J0884 |
Argatroban esrd dialysis 1mg | FRESENIUS KABI | 65219-0429-50 | ARGATROBAN | 1 MG | 50 | 1 | 50 | 50 |
J0884 |
Argatroban esrd dialysis 1mg | MYLAN INSTITUTIONAL LLC | 67457-0212-02 | Argatroban | 1 MG | 2.5 | 1 | 250 | 250 |
J0899 |
Argatroban dialysis, auromed | AUROMEDICS PHARMA LLC | 55150-0241-01 | Argatroban | 1 MG | 50 | 1 | 50 | 50 |
J0899 |
Argatroban dialysis, auromed | AUROMEDICS PHARMA LLC | 55150-0241-10 | ARGATROBAN | 1 MG | 50 | 10 | 50 | 500 |
J1096 |
Dexametha opth insert 0.1 mg | OCULAR THERAPEUTIX | 70382-0204-01 | Dextenza | 0.1 MG | 1 | 1 | 4 | 4 |
J1096 |
Dexametha opth insert 0.1 mg | OCULAR THERAPEUTIX | 70382-0204-10 | Dextenza | 0.1 MG | 1 | 10 | 4 | 40 |
J1097 |
Phenylep ketorolac opth soln | OMEROS CORPORATION | 62225-0600-04 | Omidria (phenylephrine 1% + ketorolac 0.3% irrigation) | 1 ML | 4 | 4 | 4 | 16 |
J1411 |
Inj, hemgenix, per tx dose | CSL Behring | 00053-0100-10 | Hemgenix | Per Therapeutic Dose | 10 | 10 | 1 | 1 |
J1411 |
Inj, hemgenix, per tx dose | CSL Behring | 00053-0110-11 | Hemgenix | Per Therapeutic Dose | 10 | 11 | 1 | 1 |
J1411 |
Inj, hemgenix, per tx dose | CSL Behring | 00053-0120-12 | Hemgenix | Per Therapeutic Dose | 10 | 12 | 1 | 1 |
J1411 |
Inj, hemgenix, per tx dose | CSL Behring | 00053-0130-13 | Hemgenix | Per Therapeutic Dose | 10 | 13 | 1 | 1 |
J1411 |
Inj, hemgenix, per tx dose | CSL Behring | 00053-0140-14 | Hemgenix | Per Therapeutic Dose | 10 | 14 | 1 | 1 |
J1411 |
Inj, hemgenix, per tx dose | CSL Behring | 00053-0150-15 | Hemgenix | Per Therapeutic Dose | 10 | 15 | 1 | 1 |
J1411 |
Inj, hemgenix, per tx dose | CSL Behring | 00053-0160-16 | Hemgenix | Per Therapeutic Dose | 10 | 16 | 1 | 1 |
J1411 |
Inj, hemgenix, per tx dose | CSL Behring | 00053-0170-17 | Hemgenix | Per Therapeutic Dose | 10 | 17 | 1 | 1 |
J1411 |
Inj, hemgenix, per tx dose | CSL Behring | 00053-0180-18 | Hemgenix | Per Therapeutic Dose | 10 | 18 | 1 | 1 |
J1411 |
Inj, hemgenix, per tx dose | CSL Behring | 00053-0190-19 | Hemgenix | Per Therapeutic Dose | 10 | 19 | 1 | 1 |
J1411 |
Inj, hemgenix, per tx dose | CSL Behring | 00053-0200-20 | Hemgenix | Per Therapeutic Dose | 10 | 20 | 1 | 1 |
J1411 |
Inj, hemgenix, per tx dose | CSL Behring | 00053-0210-21 | Hemgenix | Per Therapeutic Dose | 10 | 21 | 1 | 1 |
J1411 |
Inj, hemgenix, per tx dose | CSL Behring | 00053-0220-22 | Hemgenix | Per Therapeutic Dose | 10 | 22 | 1 | 1 |
J1411 |
Inj, hemgenix, per tx dose | CSL Behring | 00053-0230-23 | Hemgenix | Per Therapeutic Dose | 10 | 23 | 1 | 1 |
J1411 |
Inj, hemgenix, per tx dose | CSL Behring | 00053-0240-24 | Hemgenix | Per Therapeutic Dose | 10 | 24 | 1 | 1 |
J1411 |
Inj, hemgenix, per tx dose | CSL Behring | 00053-0250-25 | Hemgenix | Per Therapeutic Dose | 10 | 25 | 1 | 1 |
J1411 |
Inj, hemgenix, per tx dose | CSL Behring | 00053-0260-26 | Hemgenix | Per Therapeutic Dose | 10 | 26 | 1 | 1 |
J1411 |
Inj, hemgenix, per tx dose | CSL Behring | 00053-0270-27 | Hemgenix | Per Therapeutic Dose | 10 | 27 | 1 | 1 |
J1411 |
Inj, hemgenix, per tx dose | CSL Behring | 00053-0280-28 | Hemgenix | Per Therapeutic Dose | 10 | 28 | 1 | 1 |
J1411 |
Inj, hemgenix, per tx dose | CSL Behring | 00053-0290-29 | Hemgenix | Per Therapeutic Dose | 10 | 29 | 1 | 1 |
J1411 |
Inj, hemgenix, per tx dose | CSL Behring | 00053-0300-30 | Hemgenix | Per Therapeutic Dose | 10 | 30 | 1 | 1 |
J1411 |
Inj, hemgenix, per tx dose | CSL Behring | 00053-0310-31 | Hemgenix | Per Therapeutic Dose | 10 | 31 | 1 | 1 |
J1411 |
Inj, hemgenix, per tx dose | CSL Behring | 00053-0320-32 | Hemgenix | Per Therapeutic Dose | 10 | 32 | 1 | 1 |
J1411 |
Inj, hemgenix, per tx dose | CSL Behring | 00053-0330-33 | Hemgenix | Per Therapeutic Dose | 10 | 33 | 1 | 1 |
J1411 |
Inj, hemgenix, per tx dose | CSL Behring | 00053-0340-34 | Hemgenix | Per Therapeutic Dose | 10 | 34 | 1 | 1 |
J1411 |
Inj, hemgenix, per tx dose | CSL Behring | 00053-0350-35 | Hemgenix | Per Therapeutic Dose | 10 | 35 | 1 | 1 |
J1411 |
Inj, hemgenix, per tx dose | CSL Behring | 00053-0360-36 | Hemgenix | Per Therapeutic Dose | 10 | 36 | 1 | 1 |
J1411 |
Inj, hemgenix, per tx dose | CSL Behring | 00053-0370-37 | Hemgenix | Per Therapeutic Dose | 10 | 37 | 1 | 1 |
J1411 |
Inj, hemgenix, per tx dose | CSL Behring | 00053-0380-38 | Hemgenix | Per Therapeutic Dose | 10 | 38 | 1 | 1 |
J1411 |
Inj, hemgenix, per tx dose | CSL Behring | 00053-0390-39 | Hemgenix | Per Therapeutic Dose | 10 | 39 | 1 | 1 |
J1411 |
Inj, hemgenix, per tx dose | CSL Behring | 00053-0400-40 | Hemgenix | Per Therapeutic Dose | 10 | 40 | 1 | 1 |
J1411 |
Inj, hemgenix, per tx dose | CSL Behring | 00053-0410-41 | Hemgenix | Per Therapeutic Dose | 10 | 41 | 1 | 1 |
J1411 |
Inj, hemgenix, per tx dose | CSL Behring | 00053-0420-42 | Hemgenix | Per Therapeutic Dose | 10 | 42 | 1 | 1 |
J1411 |
Inj, hemgenix, per tx dose | CSL Behring | 00053-0430-43 | Hemgenix | Per Therapeutic Dose | 10 | 43 | 1 | 1 |
J1411 |
Inj, hemgenix, per tx dose | CSL Behring | 00053-0440-44 | Hemgenix | Per Therapeutic Dose | 10 | 44 | 1 | 1 |
J1411 |
Inj, hemgenix, per tx dose | CSL Behring | 00053-0450-45 | Hemgenix | Per Therapeutic Dose | 10 | 45 | 1 | 1 |
J1411 |
Inj, hemgenix, per tx dose | CSL Behring | 00053-0460-46 | Hemgenix | Per Therapeutic Dose | 10 | 46 | 1 | 1 |
J1411 |
Inj, hemgenix, per tx dose | CSL Behring | 00053-0470-47 | Hemgenix | Per Therapeutic Dose | 10 | 47 | 1 | 1 |
J1411 |
Inj, hemgenix, per tx dose | CSL Behring | 00053-0480-48 | Hemgenix | Per Therapeutic Dose | 10 | 48 | 1 | 1 |
J1426 |
Injection, casimersen, 10 mg | SAREPTA | 60923-0227-02 | Amondys 45 | 10 MG | 2 | 1 | 10 | 10 |
J1427 |
Inj. viltolarsen | NS PHARMA INC | 73292-0011-01 | Viltepso | 10 MG | 5 | 1 | 25 | 25 |
J1429 |
Inj golodirsen 10 mg | SAREPTA | 60923-0465-02 | Vyondys 53 | 10 MG | 2 | 1 | 10 | 10 |
J1438 |
Etanercept injection | AMGEN USA, INC. | 58406-0425-34 | Enbrel | 25 MG | 1 | 4 | 1 | 4 |
J1438 |
Etanercept injection | AMGEN USA, INC. | 58406-0445-04 | Enbrel | 25 MG | 1 | 4 | 2 | 8 |
J1438 |
Etanercept injection | AMGEN USA, INC. | 58406-0455-04 | Enbrel | 25 MG | 0.5 | 4 | 1 | 4 |
J1438 |
Etanercept injection | AMGEN USA, INC. | 58406-0435-04 | Enbrel (Etanercept) | 25 MG | 1 | 4 | 2 | 8 |
J1451 |
Fomepizole, 15 mg | AMERICAN REGENT | 00517-0710-01 | FOMEPIZOLE | 15 MG | 1.5 | 1 | 100 | 100 |
J1451 |
Fomepizole, 15 mg | MYLAN INSTITUTIONAL LLC | 67457-0211-02 | FOMEPIZOLE | 15 MG | 1.5 | 1 | 100 | 100 |
J1451 |
Fomepizole, 15 mg | ZYDUS PHARMACEUTICALS | 70710-1478-01 | Fomepizole | 15 MG | 1.5 | 1 | 100 | 100 |
J1455 |
Foscarnet sodium injection | SAGENT PHARMACEUTICALS INC | 25021-0189-84 | FOSCARNET SODIUM | 1000 MG | 250 | 10 | 6 | 60 |
J1455 |
Foscarnet sodium injection | FRESENIUS KABI | 63323-0875-50 | Foscarnet Sodium | 1000 MG | 250 | 1 | 6 | 6 |
J1572 |
Flebogamma injection | GRIFOLS USA, LLC | 61953-0005-01 | FLEBOGAMMA 10% DIF | 500 MG | 50 | 1 | 10 | 10 |
J1572 |
Flebogamma injection | GRIFOLS USA, LLC | 61953-0005-02 | FLEBOGAMMA 10% DIF | 500 MG | 100 | 1 | 20 | 20 |
J1572 |
Flebogamma injection | GRIFOLS USA, LLC | 61953-0005-03 | FLEBOGAMMA 10% DIF | 500 MG | 200 | 1 | 40 | 40 |
J1572 |
Flebogamma injection | GRIFOLS USA, LLC | 61953-0004-02 | Flebogamma DIF | 500 MG | 50 | 1 | 5 | 5 |
J1572 |
Flebogamma injection | GRIFOLS USA, LLC | 61953-0004-03 | Flebogamma DIF | 500 MG | 100 | 1 | 10 | 10 |
J1572 |
Flebogamma injection | GRIFOLS USA, LLC | 61953-0004-04 | Flebogamma DIF | 500 MG | 200 | 1 | 20 | 20 |
J1572 |
Flebogamma injection | GRIFOLS USA, LLC | 61953-0004-05 | Flebogamma DIF | 500 MG | 400 | 1 | 40 | 40 |
J1573 |
Hepagam b intravenous, inj | SAOL THERAPEUTICS | 70257-0051-51 | Hepagam B | 0.5 ML | 5 | 1 | 10 | 10 |
J1573 |
Hepagam b intravenous, inj | SAOL THERAPEUTICS | 70257-0052-51 | HEPAGAM B | 0.5 ML | 1 | 1 | 2 | 2 |
J1573 |
Hepagam b intravenous, inj | SAOL THERAPEUTICS | 70257-0053-51 | Hepagam B | 0.5 ML | 1 | 1 | 2 | 2 |
J1573 |
Hepagam b intravenous, inj | SAOL THERAPEUTICS | 70257-0054-51 | Hepagam B | 0.5 ML | 5 | 1 | 10 | 10 |
J1595 |
Injection glatiramer acetate | TEVA NEUROSCIENCE, INC. | 68546-0317-30 | Copaxone | 20 MG | 1 | 30 | 1 | 30 |
J1595 |
Injection glatiramer acetate | TEVA NEUROSCIENCE, INC. | 68546-0325-12 | Copaxone | 20 MG | 1 | 12 | 2 | 24 |
J1628 |
Inj., guselkumab, 1 mg | JANSSEN BIOTECH, INC. | 57894-0640-01 | Tremfya | 1 MG | 1 | 1 | 100 | 100 |
J1628 |
Inj., guselkumab, 1 mg | JANSSEN BIOTECH, INC. | 57894-0640-11 | Tremfya | 1 MG | 1 | 1 | 100 | 100 |
J1632 |
Inj, brexanolone | SAGE THERAPEUTICS | 72152-0547-20 | Zulresso | 1 MG | 20 | 1 | 100 | 100 |
J1726 |
Inj, Makena | AMERICAN REGENT | 00517-1767-01 | MAKENA | 10 MG | 1 | 1 | 25 | 25 |
J1726 |
Inj, Makena | AMAG PHARMACEUTICALS, INC. | 64011-0247-02 | MAKENA | 10 MG | 1 | 1 | 25 | 25 |
J1726 |
Inj, Makena | AMAG PHARMACEUTICALS, INC. | 64011-0301-03 | Makena Auto Injector | 10 MG | 1.1 | 1 | 27.5 | 27.5 |
J1726 |
Inj, Makena | AMERICAN REGENT | 00517-1791-01 | Hydroxyprogesterone Caproate | 10 MG | 1 | 1 | 25 | 25 |
J1726 |
Inj, Makena | AUROMEDICS PHARMA LLC | 55150-0309-01 | Hydroxyprogesterone Caproate | 10 MG | 1 | 1 | 25 | 25 |
J1726 |
Inj, Makena | AUROMEDICS PHARMA LLC | 55150-0310-01 | Hydroxyprogesterone Caproate | 10 MG | 5 | 1 | 125 | 125 |
J1726 |
Inj, Makena | MYLAN INSTITUTIONAL LLC | 67457-0886-05 | Hydroxyprogesterone Caproate | 10 MG | 1 | 1 | 125 | 125 |
J1726 |
Inj, Makena | MYLAN INSTITUTIONAL LLC | 67457-0967-01 | Hydroxyprogesterone Caproate | 10 MG | 1 | 1 | 25 | 25 |
J1726 |
Inj, Makena | AMNEAL PHARMACEUTICALS, LLC | 69238-1797-01 | Hydroxyprogesterone Caproate | 10 MG | 1 | 1 | 25 | 25 |
J1726 |
Inj, Makena | SLAYBACK PHARMA | 71225-0104-01 | Hydroxyprogesterone Caproate | 10 MG | 5 | 1 | 125 | 125 |
J1726 |
Inj, Makena | SLAYBACK PHARMA | 71225-0105-01 | Hydroxyprogesterone Caproate | 10 MG | 1 | 1 | 25 | 25 |
J1742 |
Ibutilide fumarate injection | MYLAN INSTITUTIONAL LLC | 67457-0366-10 | IBUTILIDE FUMARATE | 1 MG | 10 | 1 | 1 | 1 |
J1742 |
Ibutilide fumarate injection | PFIZER INC. | 00009-3794-01 | Corvert | 1 MG | 10 | 1 | 1 | 1 |
J1742 |
Ibutilide fumarate injection | PFIZER INC. | 00009-3794-22 | Corvert | 1 MG | 10 | 1 | 1 | 1 |
J1744 |
Icatibant injection | LEUCADIA PHARMACEUTICALS | 24201-0207-01 | ICATIBANT | 1 MG | 3 | 1 | 30 | 30 |
J1744 |
Icatibant injection | LEUCADIA PHARMACEUTICALS | 24201-0207-03 | ICATIBANT | 1 MG | 3 | 3 | 30 | 90 |
J1744 |
Icatibant injection | TAKEDA PHARMACEUTICALS AMERICA, INC. | 54092-0702-02 | ICATIBANT | 1 MG | 3 | 1 | 30 | 30 |
J1744 |
Icatibant injection | TAKEDA PHARMACEUTICALS AMERICA, INC. | 54092-0702-03 | ICATIBANT | 1 MG | 3 | 3 | 30 | 90 |
J1744 |
Icatibant injection | FRESENIUS KABI | 63323-0574-86 | ICATIBANT | 1 MG | 3 | 1 | 30 | 30 |
J1744 |
Icatibant injection | FRESENIUS KABI | 63323-0574-93 | ICATIBANT | 1 MG | 3 | 3 | 30 | 90 |
J1744 |
Icatibant injection | CIPLA USA INC. | 69097-0664-34 | ICATIBANT | 1 MG | 3 | 1 | 30 | 30 |
J1744 |
Icatibant injection | CIPLA USA INC. | 69097-0664-68 | ICATIBANT | 1 MG | 3 | 3 | 30 | 90 |
J1833 |
Inj, isavuconazonium sulfate | ASTELLAS | 00469-0420-01 | CRESEMBA | 1 MG | 1 | 1 | 372 | 372 |
J1833 |
Inj, isavuconazonium sulfate | ASTELLAS PHARMA US INC. | 00469-0420-99 | CRESEMBA injection | 1mg (as sulfate) | 1 | 10 | 372 | 3720 |
J2186 |
Inj., meropenem, vaborbactam | MELINTA THERAPEUTICS, INC. | 70842-0120-06 | Vabomere (meropenem-vaborbactam) | (10 MG/10MG) 20 MG | 1 | 6 | 100 | 600 |
J2265 |
Minocycline hydrochloride | MELINTA THERAPEUTICS, INC. | 70842-0160-10 | MINOCIN | 1 MG | 1 | 10 | 100 | 1000 |
J2326 |
Injection, nusinersen | BIOGEN | 64406-0058-01 | Spinraza | 0.1 MG | 5 | 1 | 120 | 120 |
J2403 |
Chloroprocaine opht gel, 1mg | Harrow Eye, Llc. | 82667-0300-01 | IHEEZO | 1 MG | 1 | 1 | 800 | 800 |
J2502 |
Inj, pasireotide long acting | NOVARTIS PHARMACEUTICALS CORPORATION | 00078-0641-81 | Signifor LAR | 1 MG | 1 | 1 | 20 | 20 |
J2502 |
Inj, pasireotide long acting | NOVARTIS PHARMACEUTICALS CORPORATION | 00078-0642-81 | Signifor LAR | 1 MG | 1 | 1 | 40 | 40 |
J2502 |
Inj, pasireotide long acting | NOVARTIS PHARMACEUTICALS CORPORATION | 00078-0643-81 | Signifor LAR | 1 MG | 1 | 1 | 60 | 60 |
J2502 |
Inj, pasireotide long acting | NOVARTIS PHARMACEUTICALS CORPORATION | 00078-0741-81 | Signifor LAR | 1 MG | 1 | 1 | 30 | 30 |
J2502 |
Inj, pasireotide long acting | NOVARTIS PHARMACEUTICALS CORPORATION | 00078-0748-81 | Signifor LAR | 1 MG | 1 | 1 | 10 | 10 |
J2502 |
Inj, pasireotide long acting | RECORDATI RARE DISEASES | 55292-0139-01 | Signifor Lar | 1 MG | 1 | 1 | 10 | 10 |
J2502 |
Inj, pasireotide long acting | RECORDATI RARE DISEASES | 55292-0140-01 | Signifor Lar | 1 MG | 1 | 1 | 20 | 20 |
J2502 |
Inj, pasireotide long acting | RECORDATI RARE DISEASES | 55292-0141-01 | Signifor Lar | 1 MG | 1 | 1 | 30 | 30 |
J2502 |
Inj, pasireotide long acting | RECORDATI RARE DISEASES | 55292-0142-01 | Signifor Lar | 1 MG | 1 | 1 | 40 | 40 |
J2502 |
Inj, pasireotide long acting | RECORDATI RARE DISEASES | 55292-0143-01 | Signifor Lar | 1 MG | 1 | 1 | 60 | 60 |
J2510 |
Penicillin g procaine inj | PFIZER INC. | 60793-0130-10 | Penicillin G Procaine | up to 600000 UNITS | 1 | 10 | 1 | 10 |
J2510 |
Penicillin g procaine inj | PFIZER INC. | 60793-0131-10 | Penicillin G Procaine | up to 600000 UNITS | 2 | 10 | 2 | 20 |
J2515 |
Pentobarbital sodium inj | AKORN | 17478-0181-20 | Pentobarbital | 50 MG | 20 | 1 | 20 | 20 |
J2515 |
Pentobarbital sodium inj | AKORN | 17478-0181-50 | Pentobarbital | 50 MG | 50 | 1 | 50 | 50 |
J2515 |
Pentobarbital sodium inj | LEUCADIA PHARMACEUTICALS | 24201-0010-20 | Pentobarbital | 50 MG | 20 | 1 | 20 | 20 |
J2515 |
Pentobarbital sodium inj | LEUCADIA PHARMACEUTICALS | 24201-0010-50 | Pentobarbital | 50 MG | 50 | 1 | 50 | 50 |
J2515 |
Pentobarbital sodium inj | SAGENT PHARMACEUTICALS INC | 25021-0676-20 | Pentobarbital | 50 MG | 20 | 1 | 20 | 20 |
J2515 |
Pentobarbital sodium inj | SAGENT PHARMACEUTICALS INC | 25021-0676-50 | Pentobarbital | 50 MG | 50 | 1 | 50 | 50 |
J2515 |
Pentobarbital sodium inj | OAK | 76478-0501-20 | Nembutal | 50 MG | 20 | 1 | 20 | 20 |
J2515 |
Pentobarbital sodium inj | OAK | 76478-0501-50 | Nembutal | 50 MG | 50 | 1 | 50 | 50 |
J2547 |
Injection, peramivir | BIOCRYST | 72769-0181-03 | Rapivab | 1 MG | 20 | 3 | 200 | 600 |
J2770 |
Quinupristin/dalfopristin | PFIZER INC. | 61570-0260-10 | Synercid | 500 MG | 1 | 10 | 1 | 10 |
J2840 |
Injection, sebelipase alfa | ALEXION PHARMACEUTICALS | 25682-0007-01 | Kanuma | 1 MG | 10 | 1 | 20 | 20 |
J2850 |
Inj secretin synthetic human | CHIRHOCLIN, INC. | 67066-0005-01 | CHIRHOSTIM | 1 MCG | 1 | 1 | 16 | 16 |
J2993 |
Reteplase injection | CHIESI USA, INC. | 10122-0141-02 | RETAVASE KIT | 18.1 MG | 1 | 2 | 1 | 2 |
J2998 |
Inj plasminogen tvmh 1mg | Prometic | 70573-0099-01 | Ryplazim | 1 mg | 1 | 1 | 68.8 | 68.8 |
J2998 |
Inj plasminogen tvmh 1mg | Prometic | 70573-0099-02 | Ryplazim | 1 mg | 1 | 1 | 68.8 | 68.8 |
J3031 |
Inj., fremanezumab-vfrm 1 mg | NUPATHE INC | 51759-0202-10 | Ajovy | 1 MG | 1.5 | 1 | 225 | 225 |
J3031 |
Inj., fremanezumab-vfrm 1 mg | NUPATHE INC | 51759-0202-22 | Ajovy | 1 MG | 1.5 | 3 | 225 | 675 |
J3031 |
Inj., fremanezumab-vfrm 1 mg | NUPATHE INC | 51759-0204-10 | Ajovy | 1 MG | 1.5 | 1 | 225 | 225 |
J3316 |
Inj., triptorelin xr 3.75 mg | ARBOR PHARMACEUTICAL | 24338-0150-20 | Triptodur | 3.75 MG | 1 | 1 | 6 | 6 |
J3398 |
Inj luxturna 1 billion vec g | SPARK THERAPEUTICS, INC. | 71394-0415-01 | LUXTURNA | 1 billion vector genomes | 0.5 | 1 | 150 | 150 |
J3399 |
Inj onase abepar-xioi treat | AVEXIS | 71894-0122-03 | Zolgensma 1x5.5 mL vial and 2x8.3 mL vial Kit | per tx dose (up to 5 x10^15 vg?) | 22.1 | 1 | 1 | 1 |
J3399 |
Inj onase abepar-xioi treat | AVEXIS | 71894-0125-04 | Zolgensma 1x5.5 mL vial and 3x8.3 mL vial Kit | per tx dose (up to 5 x10^15 vg?) | 30.4 | 1 | 1 | 1 |
J3399 |
Inj onase abepar-xioi treat | AVEXIS | 71894-0128-05 | Zolgensma 1x5.5 mL vial and 4x8.3 mL vial Kit | per tx dose (up to 5 x10^15 vg?) | 38.7 | 1 | 1 | 1 |
J3399 |
Inj onase abepar-xioi treat | AVEXIS | 71894-0131-06 | Zolgensma 1x5.5 mL vial and 5x8.3 mL vial Kit | per tx dose (up to 5 x10^15 vg?) | 47 | 1 | 1 | 1 |
J3399 |
Inj onase abepar-xioi treat | AVEXIS | 71894-0134-07 | Zolgensma 1x5.5 mL vial and 6x8.3 mL vial Kit | per tx dose (up to 5 x10^15 vg?) | 55.3 | 1 | 1 | 1 |
J3399 |
Inj onase abepar-xioi treat | AVEXIS | 71894-0137-08 | Zolgensma 1x5.5 mL vial and 7x8.3 mL vial Kit | per tx dose (up to 5 x10^15 vg?) | 63.6 | 1 | 1 | 1 |
J3399 |
Inj onase abepar-xioi treat | AVEXIS | 71894-0140-09 | Zolgensma 1x5.5 mL vial and 9x8.3 mL vial Kit | per tx dose (up to 5 x10^15 vg?) | 71.9 | 1 | 1 | 1 |
J3399 |
Inj onase abepar-xioi treat | AVEXIS | 71894-0121-03 | Zolgensma 2x5.5 mL vial and 1x8.3 mL vial Kit | per tx dose (up to 5 x10^15 vg?) | 19.3 | 1 | 1 | 1 |
J3399 |
Inj onase abepar-xioi treat | AVEXIS | 71894-0124-04 | Zolgensma 2x5.5 mL vial and 2x8.3 mL vial Kit | per tx dose (up to 5 x10^15 vg?) | 27.6 | 1 | 1 | 1 |
J3399 |
Inj onase abepar-xioi treat | AVEXIS | 71894-0127-05 | Zolgensma 2x5.5 mL vial and 3x8.3 mL vial Kit | per tx dose (up to 5 x10^15 vg?) | 35.9 | 1 | 1 | 1 |
J3399 |
Inj onase abepar-xioi treat | AVEXIS | 71894-0130-06 | Zolgensma 2x5.5 mL vial and 4x8.3 mL vial Kit | per tx dose (up to 5 x10^15 vg?) | 44.2 | 1 | 1 | 1 |
J3399 |
Inj onase abepar-xioi treat | AVEXIS | 71894-0133-07 | Zolgensma 2x5.5 mL vial and 5x8.3 mL vial Kit | per tx dose (up to 5 x10^15 vg?) | 52.5 | 1 | 1 | 1 |
J3399 |
Inj onase abepar-xioi treat | AVEXIS | 71894-0136-08 | Zolgensma 2x5.5 mL vial and 6x8.3 mL vial Kit | per tx dose (up to 5 x10^15 vg?) | 60.8 | 1 | 1 | 1 |
J3399 |
Inj onase abepar-xioi treat | AVEXIS | 71894-0139-09 | Zolgensma 2x5.5 mL vial and 7x8.3 mL vial Kit | per tx dose (up to 5 x10^15 vg?) | 69.1 | 1 | 1 | 1 |
J3399 |
Inj onase abepar-xioi treat | AVEXIS | 71894-0120-02 | Zolgensma 2x8.3 mL vial Kit | per tx dose (up to 5 x10^15 vg?) | 16.6 | 1 | 1 | 1 |
J3399 |
Inj onase abepar-xioi treat | AVEXIS | 71894-0123-03 | Zolgensma 3x8.3 mL vial Kit | per tx dose (up to 5 x10^15 vg?) | 24.9 | 1 | 1 | 1 |
J3399 |
Inj onase abepar-xioi treat | AVEXIS | 71894-0126-04 | Zolgensma 4x8.3 mL vial Kit | per tx dose (up to 5 x10^15 vg?) | 33.2 | 1 | 1 | 1 |
J3399 |
Inj onase abepar-xioi treat | AVEXIS | 71894-0129-05 | Zolgensma 5x8.3 mL vial Kit | per tx dose (up to 5 x10^15 vg?) | 41.5 | 1 | 1 | 1 |
J3399 |
Inj onase abepar-xioi treat | AVEXIS | 71894-0132-06 | Zolgensma 6x8.3 mL vial Kit | per tx dose (up to 5 x10^15 vg?) | 49.8 | 1 | 1 | 1 |
J3399 |
Inj onase abepar-xioi treat | AVEXIS | 71894-0135-07 | Zolgensma 7x8.3 mL vial Kit | per tx dose (up to 5 x10^15 vg?) | 58.1 | 1 | 1 | 1 |
J3399 |
Inj onase abepar-xioi treat | AVEXIS | 71894-0138-08 | Zolgensma 8x8.3 mL vial Kit | per tx dose (up to 5 x10^15 vg?) | 66.4 | 1 | 1 | 1 |
J3399 |
Inj onase abepar-xioi treat | AVEXIS | 71894-0141-09 | Zolgensma 9x8.3 mL vial Kit | per tx dose (up to 5 x10^15 vg?) | 74.7 | 1 | 1 | 1 |
J7168 |
Prothrombin complex kcentra | CSL BEHRING LLC | 63833-0386-02 | Kcentra | 1 IU | 1 | 1 | 1 | 1 |
J7168 |
Prothrombin complex kcentra | CSL BEHRING LLC | 63833-0387-02 | Kcentra | 1 IU | 1 | 1 | 1 | 1 |
J7169 |
Inj andexxa, 10 mg | ASTRAZENECA PHARMACEUTICALS, LP | 00310-3200-04 | Andexxa | 10 MG | 1 | 4 | 20 | 80 |
J7169 |
Inj andexxa, 10 mg | ALEXION PHARMACEUTICALS | 69853-0102-01 | Andexxa | 10 MG | 1 | 4 | 20 | 80 |
J7342 |
Inject, ciprofloxacin otic | ALK-ABELLO INC. | 00268-8200-01 | OTIPRIO | 6 MG | 1 | 1 | 10 | 10 |
J7342 |
Inject, ciprofloxacin otic | OTONOMY, INC. | 69251-0201-01 | OTIPRIO | 6 MG | 1 | 1 | 10 | 10 |
J7352 |
Afamelanotide implant, 1 mg | CLINUVEL | 73372-0116-01 | Scenesse | 1 MG | 1 | 1 | 16 | 16 |
J7501 |
Azathioprine parenteral | HIKMA PHARMACEUTICALS USA INC. | 00143-9566-01 | AZATHIOPRINE INJECTION | 100 MG | 1 | 1 | 1 | 1 |
J7519 |
Inj. mycophenolate mofetil | GENENTECH, INC. | 00004-0298-09 | Cellcept - IV | 10 MG | 1 | 4 | 50 | 200 |
J7519 |
Inj. mycophenolate mofetil | AKORN | 17478-0422-40 | Mycophenolate Mofetil IV | 10 MG | 1 | 4 | 50 | 200 |
J7519 |
Inj. mycophenolate mofetil | AKORN | 17478-0957-40 | Mycophenolate Mofetil IV | 10 MG | 1 | 4 | 50 | 200 |
J7519 |
Inj. mycophenolate mofetil | PAR PHARMACEUTICAL, INC | 42023-0172-04 | Mycophenolate Mofetil IV | 10 MG | 1 | 4 | 50 | 200 |
J7519 |
Inj. mycophenolate mofetil | MYLAN INSTITUTIONAL LLC | 67457-0386-81 | Mycophenolate Mofetil IV | 10 MG | 1 | 4 | 50 | 200 |
J7519 |
Inj. mycophenolate mofetil | MEITHEAL PHARMACEUTICALS | 71288-0803-21 | Mycophenolate Mofetil IV | 10 MG | 1 | 4 | 50 | 200 |
J9019 |
Erwinaze injection | JAZZ PHARMACEUTICALS, INC. | 57902-0249-05 | ERWINAZE | 1,000 IU | 1 | 5 | 10 | 50 |
J9046 |
Inj, bortezomib, dr. reddy’s | DR. REDDY'S LABORATORIES, INC. | 43598-0865-60 | Bortezomib | 0.1 MG | 1 | 1 | 35 | 35 |
J9048 |
Inj, bortezomib freseniuskab | FRESENIUS KABI | 63323-0721-10 | Bortezomib | 0.1 MG | 1 | 1 | 35 | 35 |
J9057 |
Inj., copanlisib, 1 mg | BAYER HEALTHCARE PHARMACEUTICALS INC. | 50419-0385-01 | ALIQOPA | 1 MG | 1 | 1 | 60 | 60 |
J9214 |
Interferon alfa-2b inj | SCHERING CORPORATION | 00085-1133-01 | Intron-A | 1 MIL UNITS | 2.5 | 1 | 25 | 25 |
J9214 |
Interferon alfa-2b inj | SCHERING CORPORATION | 00085-1168-01 | Intron-A | 1 MIL UNITS | 3 | 1 | 18 | 18 |
J9214 |
Interferon alfa-2b inj | SCHERING CORPORATION | 00085-4350-01 | Intron-A | 1 MIL UNITS | 1 | 1 | 10 | 10 |
J9214 |
Interferon alfa-2b inj | SCHERING CORPORATION | 00085-4351-01 | Intron-A | 1 MIL UNITS | 1 | 1 | 18 | 18 |
J9214 |
Interferon alfa-2b inj | SCHERING CORPORATION | 00085-4352-01 | Intron-A | 1 MIL UNITS | 1 | 1 | 50 | 50 |
J9225 |
Vantas implant | ENDO PHARMACEUTICALS VALERA INC. | 67979-0500-01 | Vantas implant | 50 MG | 1 | 1 | 1 | 1 |
J9247 |
Inj, melphalan flufenami 1mg | ONCOPEPTIDES, INC. | 73657-0020-01 | Pepaxto | 1 MG | 1 | 1 | 20 | 20 |
J9296 |
Inj pemetrexed (accord) 10mg | Accord Healthcare Inc. | 16729-0522-05 | Pemetrexed | 10 mg | 20 | 1 | 50 | 50 |
J9296 |
Inj pemetrexed (accord) 10mg | ACCORD HEALTHCARE | 16729-0522-28 | PEMETREXED | 10 MG | 34 | 1 | 85 | 85 |
J9296 |
Inj pemetrexed (accord) 10mg | Accord Healthcare Inc. | 16729-0522-35 | Pemetrexed | 10 mg | 40 | 1 | 100 | 100 |
J9296 |
Inj pemetrexed (accord) 10mg | Accord Healthcare Inc. | 16729-0522-64 | Pemetrexed | 10 mg | 4 | 1 | 10 | 10 |
J9314 |
Inj pemetrexed (teva) 10mg | TEVA PHARMACEUTICALS USA, INC. | 00480-4514-01 | Pemetrexed | 10 MG | 20 | 1 | 50 | 50 |
J9314 |
Inj pemetrexed (teva) 10mg | TEVA PHARMACEUTICALS USA, INC. | 00480-4515-01 | Pemetrexed | 10 MG | 40 | 1 | 100 | 100 |
J9314 |
Inj pemetrexed (teva) 10mg | TEVA PHARMACEUTICALS USA, INC. | 00480-4516-01 | Pemetrexed | 10 MG | 4 | 1 | 10 | 10 |
J9318 |
Inj romidepsin non-lyo 0.1mg | SICOR PHARMACEUTICALS, INC. | 00703-4004-01 | Romidepsin non-lyophilized | 0.1 MG | 5.5 | 1 | 275 | 275 |
J9320 |
Streptozocin injection | SICOR PHARMACEUTICALS, INC. | 00703-4636-01 | Zanosar | 1 GM | 1 | 1 | 1 | 1 |
J9345 |
Inj, retifanlimab-dlwr, 1 mg | Incyte Corporation | 50881-0006-03 | Zynyz | 1 MG | 20 | 1 | 500 | 500 |
J9371 |
Inj, Vincristine sul lip 1mg | SPECTRUM PHARMACEUTICALS | 20536-0322-01 | Vincristine Sulfate | 1 MG | 1 | 1 | 5 | 5 |
J9371 |
Inj, Vincristine sul lip 1mg | ACROTECH BIOPHARMA | 72893-0008-03 | Vincristine Sulfate | 1 MG | 1 | 1 | 5 | 5 |
J9393 |
Inj, fulvestrant (teva) | ACTAVIS PHARMA, INC. | 00591-5019-02 | FULVESTRANT | 25 MG | 5 | 2 | 10 | 20 |
J9600 |
Porfimer sodium injection | PINNACLE BIOLOGICS, INC. | 76128-0155-75 | Photofrin | 75 MG | 1 | 1 | 1 | 1 |
Q5120 |
Inj pegfilgrastim-bmez 0.5mg | SANDOZ | 61314-0866-01 | ZIEXTENZO | 0.5 MG | 0.6 | 1 | 12 | 12 |
Q9968 |
Visualization adjunct | AMERICAN REGENT | 00517-0374-05 | Provayblue | 1 MG | 10 | 5 | 50 | 250 |
Q9968 |
Visualization adjunct | MYLAN INSTITUTIONAL LLC | 67457-0220-05 | ISOSULFAN BLUE INJECTION | 1 MG | 5 | 6 | 50 | 300 |